/
covid19.bib
8702 lines (8702 loc) · 930 KB
/
covid19.bib
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
561
562
563
564
565
566
567
568
569
570
571
572
573
574
575
576
577
578
579
580
581
582
583
584
585
586
587
588
589
590
591
592
593
594
595
596
597
598
599
600
601
602
603
604
605
606
607
608
609
610
611
612
613
614
615
616
617
618
619
620
621
622
623
624
625
626
627
628
629
630
631
632
633
634
635
636
637
638
639
640
641
642
643
644
645
646
647
648
649
650
651
652
653
654
655
656
657
658
659
660
661
662
663
664
665
666
667
668
669
670
671
672
673
674
675
676
677
678
679
680
681
682
683
684
685
686
687
688
689
690
691
692
693
694
695
696
697
698
699
700
701
702
703
704
705
706
707
708
709
710
711
712
713
714
715
716
717
718
719
720
721
722
723
724
725
726
727
728
729
730
731
732
733
734
735
736
737
738
739
740
741
742
743
744
745
746
747
748
749
750
751
752
753
754
755
756
757
758
759
760
761
762
763
764
765
766
767
768
769
770
771
772
773
774
775
776
777
778
779
780
781
782
783
784
785
786
787
788
789
790
791
792
793
794
795
796
797
798
799
800
801
802
803
804
805
806
807
808
809
810
811
812
813
814
815
816
817
818
819
820
821
822
823
824
825
826
827
828
829
830
831
832
833
834
835
836
837
838
839
840
841
842
843
844
845
846
847
848
849
850
851
852
853
854
855
856
857
858
859
860
861
862
863
864
865
866
867
868
869
870
871
872
873
874
875
876
877
878
879
880
881
882
883
884
885
886
887
888
889
890
891
892
893
894
895
896
897
898
899
900
901
902
903
904
905
906
907
908
909
910
911
912
913
914
915
916
917
918
919
920
921
922
923
924
925
926
927
928
929
930
931
932
933
934
935
936
937
938
939
940
941
942
943
944
945
946
947
948
949
950
951
952
953
954
955
956
957
958
959
960
961
962
963
964
965
966
967
968
969
970
971
972
973
974
975
976
977
978
979
980
981
982
983
984
985
986
987
988
989
990
991
992
993
994
995
996
997
998
999
1000
@misc{Gelzinis2020,
author = {Gelzinis, Theresa A},
booktitle = {Journal of cardiothoracic and vascular anesthesia},
doi = {10.1053/j.jvca.2020.05.008},
issn = {1532-8422 (Electronic)},
language = {eng},
month = {sep},
number = {9},
pages = {2328--2330},
pmid = {32406428},
title = {{Thoracic Anesthesia in the Coronavirus Disease 2019 (COVID-19) Era.}},
volume = {34},
year = {2020}
}
@article{Coccia2020,
abstract = {This study has two goals. The first is to explain the geo-environmental determinants of the accelerated diffusion of COVID-19 that is generating a high level of deaths. The second is to suggest a strategy to cope with future epidemic threats similar to COVID-19 having an accelerated viral infectivity in society. Using data on sample of N = 55 Italian province capitals, and data of infected individuals at as of April 7th, 2020, results reveal that the accelerate and vast diffusion of COVID-19 in North Italy has a high association with air pollution of cities measured with days exceeding the limits set for PM(10) (particulate matter 10 $\mu$m or less in diameter) or ozone. In particular, hinterland cities with average high number of days exceeding the limits set for PM(10) (and also having a low wind speed) have a very high number of infected people on 7th April 2020 (arithmetic mean is about 2200 infected individuals, with average polluted days greater than 80 days per year), whereas coastal cities also having days exceeding the limits set for PM(10) or ozone but with high wind speed have about 944.70 average infected individuals, with about 60 average polluted days per year; moreover, cities having more than 100 days of air pollution (exceeding the limits set for PM(10)), they have a very high average number of infected people (about 3350 infected individuals, 7th April 2020), whereas cities having less than 100 days of air pollution per year, they have a lower average number of infected people (about 1014 individuals). The findings here also suggest that to minimize the impact of future epidemics similar to COVID-19, the max number of days per year that Italian provincial capitals or similar industrialized cities can exceed the limits set for PM(10) or for ozone, considering their meteorological conditions, is about 48 days. Moreover, results here reveal that the explanatory variable of air pollution in cities seems to be a more important predictor in the initial phase of diffusion of viral infectivity (on 17th March 2020, b(1) = 1.27, p {\textless} 0.001) than interpersonal contacts (b(2) = 0.31, p {\textless} 0.05). In the second phase of maturity of the transmission dynamics of COVID-19, air pollution reduces intensity (on 7th April 2020 with b'(1) = 0.81, p {\textless} 0.001) also because of the indirect effect of lockdown, whereas regression coefficient of transmission based on interpersonal contacts has a stable level (b'(2) = 0.31, p {\textless} 0.01). This result reveals that accelerated transmission dynamics of COVID-19 is due to mainly to the mechanism of "air pollution-to-human transmission" (airborne viral infectivity) rather than "human-to-human transmission". Overall, then, transmission dynamics of viral infectivity, such as COVID-19, is due to systemic causes: general factors that are the same for all regions (e.g., biological characteristics of virus, incubation period, etc.) and specific factors which are different for each region and/or city (e.g., complex interaction between air pollution, meteorological conditions and biological characteristics of viral infectivity) and health level of individuals (habits, immune system, age, sex, etc.). Lessons learned for COVID-19 in the case study here suggest that a proactive strategy to cope with future epidemics is also to apply especially an environmental and sustainable policy based on reduction of levels of air pollution mainly in hinterland and polluting cities- (having low wind speed, high percentage of moisture and number of fog days) -that seem to have an environment that foster a fast transmission dynamics of viral infectivity in society. Hence, in the presence of polluting industrialization in regions that can trigger the mechanism of air pollution-to-human transmission dynamics of viral infectivity, this study must conclude that a comprehensive strategy to prevent future epidemics similar to COVID-19 has to be also designed in environmental and socioeconomic terms, that is also based on sustainability science and environmental science, and not only in terms of biology, medicine, healthcare and health sector.},
author = {Coccia, Mario},
doi = {10.1016/j.scitotenv.2020.138474},
issn = {1879-1026 (Electronic)},
journal = {The Science of the total environment},
keywords = {Air Pollutants,Air Pollution,Betacoronavirus,Cities,Coronavirus Infections,Humans,Italy,Pandemics,Particulate Matter,Pneumonia, Viral},
language = {eng},
month = {aug},
pages = {138474},
pmid = {32498152},
title = {{Factors determining the diffusion of COVID-19 and suggested strategy to prevent future accelerated viral infectivity similar to COVID.}},
volume = {729},
year = {2020}
}
@article{Ataguba2020,
abstract = {The coronavirus disease 2019 (COVID-19) pandemic has affected many countries with increasing morbidity and mortality. Interestingly, many of the actions and policies adopted in countries are linked to the social determinants of health (SDH). The SDH are critical determinants of health and health inequalities that are not directly within the health sector. Policies such as social distancing, good hygiene, avoiding large gatherings, cancelling of social and sports events, using personal protective equipment, schools and restaurants closure, country lockdown, etc. are not necessarily within the health sector but have been promoted to prevent and attenuate COVID-19 infection rates significantly. The SDH that serve to reduce morbidity will forestall or substantially reduce the pressure on many weak health systems in developing countries that cannot cope with increased hospitalisation and intensive health care. This paper argues that one of the most critical social determinants of health (i.e. effective crisis and risk communication), is crucial in many developing countries, including those with fewer confirmed coronavirus cases. We note that the effectiveness of many of the other SDH in reducing the burden of the COVID-19 pandemic hinges on effective communication, especially crisis and risk communication. Although many countries are adopting different communication strategies during the COVID-19 crisis, effective crisis and risk communication will lead to building trust, credibility, honesty, transparency, and accountability. The peculiarity of many developing countries in terms of regional, cultural, linguistic and ethnic diversity is an essential consideration in ensuring effective crisis and risk communication. Developing countries facing significant poverty and disease burden cannot afford to handle the burgeoning of COVID-19 infections and must take preventive measures seriously. Thus, we submit that there is a need to intensify SDH actions and ensure that no one is left behind when communicating crisis and risk to the population to address the COVID-19 pandemic.},
author = {Ataguba, Ochega A and Ataguba, John E},
doi = {10.1080/16549716.2020.1788263},
issn = {1654-9880 (Electronic)},
journal = {Global health action},
keywords = {Betacoronavirus,Communicable Disease Control,Communication,Coronavirus Infections,Delivery of Health Care,Developing Countries,Humans,Pandemics,Pneumonia, Viral,Social Determinants of Health,epidemiology,trends},
language = {eng},
month = {dec},
number = {1},
pages = {1788263},
pmid = {32657669},
title = {{Social determinants of health: the role of effective communication in the COVID-19 pandemic in developing countries.}},
volume = {13},
year = {2020}
}
@article{Sigala2020,
abstract = {The paper aims to critically review past and emerging literature to help professionals and researchers alike to better understand, manage and valorize both the tourism impacts and transformational affordance of COVID-19. To achieve this, first, the paper discusses why and how the COVID-19 can be a transformational opportunity by discussing the circumstances and the questions raised by the pandemic. By doing this, the paper identifies the fundamental values, institutions and pre-assumptions that the tourism industry and academia should challenge and break through to advance and reset the research and practice frontiers. The paper continues by discussing the major impacts, behaviours and experiences that three major tourism stakeholders (namely tourism demand, supply and destination management organisations and policy makers) are experiencing during three COVID-19 stages (response, recovery and reset). This provides an overview of the type and scale of the COVID-19 tourism impacts and implications for tourism research.},
author = {Sigala, Marianna},
doi = {10.1016/j.jbusres.2020.06.015},
issn = {0148-2963 (Print)},
journal = {Journal of business research},
language = {eng},
month = {sep},
pages = {312--321},
pmid = {32546875},
title = {{Tourism and COVID-19: Impacts and implications for advancing and resetting industry and research.}},
volume = {117},
year = {2020}
}
@misc{Liu2020f,
author = {Liu, Xu-Hui and Lu, Shui-Hua and Chen, Jun and Xia, Lu and Yang, Zong-Guo and Charles, Stratton and Yang, Yang and Lin, Yun and Lu, Hong-Zhou},
booktitle = {Emerging microbes {\&} infections},
doi = {10.1080/22221751.2020.1766383},
issn = {2222-1751 (Electronic)},
keywords = {Adolescent,Adult,Aged,Antibodies, Viral,Ascorbic Acid,Betacoronavirus,China,Coronavirus Infections,Cross-Sectional Studies,Female,Humans,Hydroxychloroquine,Immunologic Factors,Male,Middle Aged,Pandemics,Pneumonia, Viral,Severity of Illness Index,Thymalfasin,Travel,Treatment Outcome,blood,drug effects,drug therapy,epidemiology,immunology,pathogenicity,physiopathology,therapeutic use},
language = {eng},
month = {dec},
number = {1},
pages = {1230--1232},
pmid = {32515651},
title = {{Clinical characteristics of foreign-imported COVID-19 cases in Shanghai, China.}},
volume = {9},
year = {2020}
}
@article{Lechner2020,
abstract = {Amidst the coronavirus pandemic, universities across the country abruptly closed campuses and transitioned to remote learning. The effects of these unprecedented closures are unknown. The current study examined reported alcohol consumption during the week prior to and after campus closure at a public university in Northeast Ohio. Analysis of data from 1,958 students, who endorsed using alcohol in the past 30 days, demonstrates that alcohol consumption (amount and frequency) increased as time progressed. Those with more symptoms of depression and anxiety reported greater increases in alcohol consumption (assessed via retrospective timeline follow-back) compared to students with fewer symptoms. Furthermore, students with greater perceived social support reported less alcohol consumption. Together, these findings highlight the need for universities to offer services and programs to students that will minimize risk factors and maximize protective factors in order to reduce or prevent alcohol abuse during the coronavirus pandemic.},
author = {Lechner, William V and Laurene, Kimberly R and Patel, Sweta and Anderson, Megan and Grega, Chelsea and Kenne, Deric R},
doi = {10.1016/j.addbeh.2020.106527},
issn = {1873-6327 (Electronic)},
journal = {Addictive behaviors},
language = {eng},
month = {nov},
pages = {106527},
pmid = {32679435},
title = {{Changes in alcohol use as a function of psychological distress and social support following COVID-19 related University closings.}},
volume = {110},
year = {2020}
}
@article{Cagliani2020,
abstract = {In December 2019, a novel human-infecting coronavirus (SARS-CoV-2) was recognized in China. In a few months, SARS-CoV-2 has caused thousands of disease cases and deaths in several countries. Phylogenetic analyses indicated that SARS-CoV-2 clusters with SARS-CoV in the Sarbecovirus subgenus and viruses related to SARS-CoV-2 were identified from bats and pangolins. Coronaviruses have long and complex genomes with high plasticity in terms of gene content. To date, the coding potential of SARS-CoV-2 remains partially unknown. We thus used available sequences of bat and pangolin viruses to determine the selective events that shaped the genome structure of SARS-CoV-2 and to assess its coding potential. By searching for signals of significantly reduced variability at synonymous sites (dS), we identified six genomic regions, one of these corresponding to the programmed -1 ribosomal frameshift. The most prominent signal of dS reduction was observed within the E gene. A genome-wide analysis of conserved RNA structures indicated that this region harbors a putative functional RNA element that is shared with the SARS-CoV lineage. Additional signals of reduced dS indicated the presence of internal ORFs. Whereas the presence ORF9a (internal to N) was previously proposed by homology with a well characterized protein of SARS-CoV, ORF3h (for hypothetical, within ORF3a) was not previously described. The predicted product of ORF3h has 90{\%} identity with the corresponding predicted product of SARS-CoV and displays features suggestive of a viroporin. Finally, analysis of the putative ORF10 revealed high dN/dS (3.82) in SARS-CoV-2 and related coronaviruses. In the SARS-CoV lineage, the ORF is predicted to encode a truncated protein and is neutrally evolving. These data suggest that ORF10 encodes a functional protein in SARS-CoV-2 and that positive selection is driving its evolution. Experimental analyses will be necessary to validate and characterize the coding and non-coding functional elements we identified.},
author = {Cagliani, Rachele and Forni, Diego and Clerici, Mario and Sironi, Manuela},
doi = {10.1016/j.meegid.2020.104353},
issn = {1567-7257 (Electronic)},
journal = {Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases},
keywords = {Animals,Betacoronavirus,Coronavirus Infections,Gene Expression Regulation, Viral,Genome, Viral,Humans,Pandemics,Phylogeny,Pneumonia, Viral,RNA, Viral,Recombination, Genetic,Sequence Alignment,genetics,virology},
language = {eng},
month = {sep},
pages = {104353},
pmid = {32387562},
title = {{Coding potential and sequence conservation of SARS-CoV-2 and related animal viruses.}},
volume = {83},
year = {2020}
}
@article{Okba2020,
abstract = {Middle East respiratory syndrome coronavirus (MERS-CoV) is a WHO priority pathogen for which vaccines are urgently needed. Using an immune-focusing approach, we created self-assembling particles multivalently displaying critical regions of the MERS-CoV spike protein ─fusion peptide, heptad repeat 2, and receptor binding domain (RBD) ─ and tested their immunogenicity and protective capacity in rabbits. Using a "plug-and-display" SpyTag/SpyCatcher system, we coupled RBD to lumazine synthase (LS) particles producing multimeric RBD-presenting particles (RBD-LS). RBD-LS vaccination induced antibody responses of high magnitude and quality (avidity, MERS-CoV neutralizing capacity, and mucosal immunity) with cross-clade neutralization. The antibody responses were associated with blocking viral replication and upper and lower respiratory tract protection against MERS-CoV infection in rabbits. This arrayed multivalent presentation of the viral RBD using the antigen-SpyTag/LS-SpyCatcher is a promising MERS-CoV vaccine candidate and this platform may be applied for the rapid development of vaccines against other emerging viruses such as SARS-CoV-2.},
author = {Okba, Nisreen M A and Widjaja, Ivy and van Dieren, Brenda and Aebischer, Andrea and van Amerongen, Geert and de Waal, Leon and Stittelaar, Koert J and Schipper, Debby and Martina, Byron and van den Brand, Judith M A and Beer, Martin and Bosch, Berend-Jan and Haagmans, Bart L},
doi = {10.1080/22221751.2020.1760735},
issn = {2222-1751 (Electronic)},
journal = {Emerging microbes {\&} infections},
keywords = {Animals,Antibodies, Neutralizing,Antibodies, Viral,Antibody Affinity,Antibody Formation,Antigen Presentation,Binding Sites,Coronavirus Infections,Enzyme-Linked Immunosorbent Assay,Female,Genetic Vectors,HEK293 Cells,Humans,Immunogenicity, Vaccine,Middle East Respiratory Syndrome Coronavirus,Neutralization Tests,Protein Binding,Protein Domains,Rabbits,Spike Glycoprotein, Coronavirus,Viral Vaccines,Virus Replication,biosynthesis,immunology,physiology,prevention {\&} control},
language = {eng},
month = {dec},
number = {1},
pages = {1080--1091},
pmid = {32471334},
title = {{Particulate multivalent presentation of the receptor binding domain induces protective immune responses against MERS-CoV.}},
volume = {9},
year = {2020}
}
@misc{Donthu2020,
abstract = {The COVID-19 outbreak is a sharp reminder that pandemics, like other rarely occurring catastrophes, have happened in the past and will continue to happen in the future. Even if we cannot prevent dangerous viruses from emerging, we should prepare to dampen their effects on society. The current outbreak has had severe economic consequences across the globe, and it does not look like any country will be unaffected. This not only has consequences for the economy; all of society is affected, which has led to dramatic changes in how businesses act and consumers behave. This special issue is a global effort to address some of the pandemic-related issues affecting society. In total, there are 13 papers that cover different industry sectors (e.g., tourism, retail, higher education), changes in consumer behavior and businesses, ethical issues, and aspects related to employees and leadership.},
author = {Donthu, Naveen and Gustafsson, Anders},
booktitle = {Journal of business research},
doi = {10.1016/j.jbusres.2020.06.008},
issn = {0148-2963 (Print)},
language = {eng},
month = {sep},
pages = {284--289},
pmid = {32536736},
title = {{Effects of COVID-19 on business and research.}},
volume = {117},
year = {2020}
}
@article{VanDorp2020,
abstract = {SARS-CoV-2 is a SARS-like coronavirus of likely zoonotic origin first identified in December 2019 in Wuhan, the capital of China's Hubei province. The virus has since spread globally, resulting in the currently ongoing COVID-19 pandemic. The first whole genome sequence was published on January 5 2020, and thousands of genomes have been sequenced since this date. This resource allows unprecedented insights into the past demography of SARS-CoV-2 but also monitoring of how the virus is adapting to its novel human host, providing information to direct drug and vaccine design. We curated a dataset of 7666 public genome assemblies and analysed the emergence of genomic diversity over time. Our results are in line with previous estimates and point to all sequences sharing a common ancestor towards the end of 2019, supporting this as the period when SARS-CoV-2 jumped into its human host. Due to extensive transmission, the genetic diversity of the virus in several countries recapitulates a large fraction of its worldwide genetic diversity. We identify regions of the SARS-CoV-2 genome that have remained largely invariant to date, and others that have already accumulated diversity. By focusing on mutations which have emerged independently multiple times (homoplasies), we identify 198 filtered recurrent mutations in the SARS-CoV-2 genome. Nearly 80{\%} of the recurrent mutations produced non-synonymous changes at the protein level, suggesting possible ongoing adaptation of SARS-CoV-2. Three sites in Orf1ab in the regions encoding Nsp6, Nsp11, Nsp13, and one in the Spike protein are characterised by a particularly large number of recurrent mutations ({\textgreater}15 events) which may signpost convergent evolution and are of particular interest in the context of adaptation of SARS-CoV-2 to the human host. We additionally provide an interactive user-friendly web-application to query the alignment of the 7666 SARS-CoV-2 genomes.},
author = {van Dorp, Lucy and Acman, Mislav and Richard, Damien and Shaw, Liam P and Ford, Charlotte E and Ormond, Louise and Owen, Christopher J and Pang, Juanita and Tan, Cedric C S and Boshier, Florencia A T and Ortiz, Arturo Torres and Balloux, Fran{\c{c}}ois},
doi = {10.1016/j.meegid.2020.104351},
issn = {1567-7257 (Electronic)},
journal = {Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases},
keywords = {Adaptation, Physiological,Antiviral Agents,Betacoronavirus,Coronavirus Infections,Genetic Variation,Genome, Viral,Humans,Likelihood Functions,Mutation,Pandemics,Phylogeny,Pneumonia, Viral,Viral Vaccines,genetics,prevention {\&} control,virology},
language = {eng},
month = {sep},
pages = {104351},
pmid = {32387564},
title = {{Emergence of genomic diversity and recurrent mutations in SARS-CoV-2.}},
volume = {83},
year = {2020}
}
@article{Wister2020,
abstract = {The COVID-19 global crisis is reshaping Canadian society in unexpected and profound ways. The significantly higher morbidity and mortality risks by age suggest that this is largely a "gero-pandemic," which has thrust the field of aging onto center stage. This editorial emphasizes that vulnerable older adults are also those most affected by COVID-19 in terms of infection risk, negative health effects, and the potential deleterious outcomes on a range of social, psychological, and economic contexts - from ageism to social isolation. We also contend that the pathogenic analysis of this pandemic needs to be balanced with a salutogenic approach that examines the positive adaptation of people, systems and society, termed COVID-19 resilience. This begs the question: how and why do some older adults and communities adapt and thrive better than others? This examination will lead to the identification and response to research and data gaps, challenges, and innovative opportunities as we plan for a future in which COVID-19 has become another endemic infection in the growing list of emerging and re-emerging pathogens.},
author = {Wister, Andrew and Speechley, Mark},
doi = {10.1017/S0714980820000215},
issn = {1710-1107 (Electronic)},
journal = {Canadian journal on aging = La revue canadienne du vieillissement},
language = {eng},
month = {sep},
number = {3},
pages = {344--347},
pmid = {32423497},
title = {{COVID-19: Pandemic Risk, Resilience and Possibilities for Aging Research.}},
volume = {39},
year = {2020}
}
@article{Barilla2020,
abstract = {: ACE2 receptor has a broad expression pattern in the cellular membrane and provides a protective action against the development of cardiovascular diseases. Recently, this enzyme has become of extreme interest during the pandemic infection of COVID-19 (coronavirus disease 2019). This virus invades alveolar epithelium and cardiomyocytes using ACE2 as a transmembrane receptor. ACE2 is a counter-regulatory peptide that degrades Ang II into Ang 1-7, thereby attenuating the biological effects of the AT1 receptor. The binding between the spike protein of COVID-19 and the enzyme is crucial for the virus to enter the target cells, but whether an increase in ACE2 activity could facilitate the infection is not yet demonstrated. However, this aspect has raised many concerns about the use of ACE inhibitors or ARBs in infected patients or patients at risk of infection. It appears that cellular infection leads to a reduction in ACE2 expression and an increase in the activity of the Ang II--AT1 axis, which leads to the release of pro-inflammatory cytokines, ARDS, myocarditis, and hypercoagulability with the possibility of exacerbation of acute coronary syndrome, induction of pulmonary embolism, or appearance of disseminated intravascular coagulation. Therefore, ACE inhibitors or angiotensin receptor blocker drugs should be continued in infected patients, as their discontinuation can increase Ang II activity and induce injury to the lungs or cardiovascular system.},
author = {Barill{\`{a}}, Francesco and Bassareo, Pier Paolo and Calcaterra, Giuseppe and Romeo, Francesco and Mehta, Jawahar L},
doi = {10.2459/JCM.0000000000001071},
issn = {1558-2035 (Electronic)},
journal = {Journal of cardiovascular medicine (Hagerstown, Md.)},
language = {eng},
month = {sep},
number = {9},
pages = {630--633},
pmid = {32740495},
title = {{Focus on clinical practice: angiotensin-converting enzyme 2 and corona virus disease 2019: pathophysiology and clinical implications.}},
volume = {21},
year = {2020}
}
@article{Zhang2020d,
abstract = {The nucleocapsid protein is significant in the formation of viral RNA of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), accounting for the largest proportion of viral structural proteins. Here, we report for the first time that the 11S proteasomal activator PA28$\gamma$ regulates the intracellular abundance of the SARS-CoV-2 N protein (nCoV N). Furthermore, we have identified proteasome activator PA28$\gamma$ as a nCoV N binding protein by co-immunoprecipitation assay. As a result of their interaction, nCoV N could be degraded by PA28$\gamma$-20S in vitro degradation assay. This was also demonstrated by blocking de novo protein synthesis with cycloheximide. The stability of nCoV N in PA28$\gamma$-knockout cells was greater than in PA28$\gamma$-wildtype cells. Notably, immunofluorescence staining revealed that knockout of the PA28$\gamma$ gene in cells led to the transport of nCoV N from the nucleus to the cytoplasm. Overexpression of PA28$\gamma$ enhanced proteolysis of nCoV N compared to that in PA28$\gamma$-N151Y cells containing a dominant-negative PA28$\gamma$ mutation, which reduced this process. These results suggest that PA28$\gamma$ binding is important in regulating 20S proteasome activity, which in turn regulates levels of the critical nCoV N nucleocapsid protein of SARS-CoV-2, furthering our understanding of the pathogenesis of COVID-19.},
author = {Zhang, Haiyang and Tu, Jialu and Cao, Chulei and Yang, Ting and Gao, Liangcai},
doi = {10.1016/j.bbrc.2020.06.058},
issn = {1090-2104 (Electronic)},
journal = {Biochemical and biophysical research communications},
keywords = {Autoantigens,Betacoronavirus,Coronavirus Infections,HEK293 Cells,Humans,In Vitro Techniques,Nucleocapsid Proteins,Pandemics,Pneumonia, Viral,Proteasome Endopeptidase Complex,Protein Binding,Protein Stability,Protein Transport,Proteolysis,metabolism,virology},
language = {eng},
month = {aug},
number = {2},
pages = {251--256},
pmid = {32703419},
title = {{Proteasome activator PA28$\gamma$-dependent degradation of coronavirus disease (COVID-19) nucleocapsid protein.}},
volume = {529},
year = {2020}
}
@article{Peng2020,
abstract = {BACKGROUND: The COVID-19 outbreak has brought tremendous psychological pressure to the general population, which may lead to depression. Therefore, this study aim to evaluate the prevalence and clinical correlates of depressive symptoms in the general population quarantined during the COVID-19 outbreak in Shenzhen. METHODS: 2237 quarantined general individuals participated in this cross-sectional study from February 14 to March 4, 2020, during their 14 days quarantine. They completed the Zung's Self-Rating Depression Scale (SDS) for depression, Zung's self-rating anxiety scale (SAS) for anxiety, the Pittsburgh Sleep Quality Index (PSQI) for sleep quality, and the Impact of Events Scale-Revised (IES-R) for post-traumatic stress symptoms (PTSS). RESULTS: The prevalence of depressive symptom was 6.21{\%} in quarantined individuals. The depressed group were younger, less married and educated, and had higher SAS, PSQI, IES-R total scores (all p{\textless}0.05), as well as more avoidance, intrusion and hyperarousal symptoms than the non-depressed group. Correlation analysis showed significant correlations between SDS score and the following parameters: age, marriage, education, SAS, PSQI, IES-R total and its three subscale scores (Bonferroni corrected all p{\textless}0.05). Further multiple regression indicated that age, marriage, education, SAS, PSQI, IES-R total score, Avoidance and Hyperarousal factor were independent predictors of depressive symptom. LIMITATIONS: This study adopted a cross-sectional design and used self-report questionnaires. CONCLUSIONS: Our results suggest an elevated prevalence of depressive symptom in quarantined general individuals in Shenzhen. Some demographic and clinical variables were associated with depressive symptoms.},
author = {Peng, Min and Mo, Beirong and Liu, Yansong and Xu, Mingming and Song, Xinran and Liu, Luyu and Fang, Yeqing and Guo, Tianyou and Ye, Jinying and Yu, Zhijian and Deng, Qiwen and Zhang, Xiangyang},
doi = {10.1016/j.jad.2020.06.035},
issn = {1573-2517 (Electronic)},
journal = {Journal of affective disorders},
language = {eng},
month = {oct},
pages = {119--124},
pmid = {32658813},
title = {{Prevalence, risk factors and clinical correlates of depression in quarantined population during the COVID-19 outbreak.}},
volume = {275},
year = {2020}
}
@misc{Hu2020,
author = {Hu, Bo and Deng, Qing and Zhou, Qing},
booktitle = {International journal of cardiology},
doi = {10.1016/j.ijcard.2020.05.049},
issn = {1874-1754 (Electronic)},
keywords = {Betacoronavirus,Coronavirus Infections,Humans,Pandemics,Pneumonia, Viral,SARS Virus},
language = {eng},
month = {sep},
pages = {95},
pmid = {32560765},
title = {{Cardiac involvement of COVID-19: Looking forward to novel discoveries and clinically valuable evidence.}},
volume = {314},
year = {2020}
}
@misc{Shojaei2020,
abstract = {The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak resulted in 5,993,317 confirmed cases worldwide with 365,394 confirmed deaths (as of May 29(th), 2020, WHO). The molecular mechanism of virus infection and spread in the body is not yet disclosed, but studies on other betacoronaviruses show that, upon cell infection, these viruses inhibit macroautophagy/autophagy flux and cause the accumulation of autophagosomes. No drug has yet been approved for the treatment of SARS-CoV-2 infection; however, preclinical investigations suggested repurposing of several FDA-approved drugs for clinical trials. Half of these drugs are modulators of the autophagy pathway. Unexpectedly, instead of acting by directly antagonizing the effects of viruses, these drugs appear to function by suppressing autophagy flux. Based on the established cross-talk between autophagy and apoptosis, we speculate that over-accumulation of autophagosomes activates an apoptotic pathway that results in apoptotic death of the infected cells and disrupts the virus replication cycle. However, administration of the suggested drugs are associated with severe adverse effects due to their off-target accumulation. Nanoparticle targeting of autophagy at the sites of interest could be a powerful tool to efficiently overcome SARS-CoV-2 infection while avoiding the common adverse effects of these drugs.},
author = {Shojaei, Shahla and Suresh, Madhumita and Klionsky, Daniel J and Labouta, Hagar Ibrahim and Ghavami, Saeid},
booktitle = {Virulence},
doi = {10.1080/21505594.2020.1780088},
issn = {2150-5608 (Electronic)},
keywords = {Autophagy,Betacoronavirus,Coronavirus Infections,Humans,Pandemics,Pneumonia, Viral,pathogenicity,pathology,virology},
language = {eng},
month = {dec},
number = {1},
pages = {805--810},
pmid = {32567972},
title = {{Autophagy and SARS-CoV-2 infection: Apossible smart targeting of the autophagy pathway.}},
volume = {11},
year = {2020}
}
@article{Baussano2020,
author = {Baussano, Iacopo and Sankaranarayanan, Rengaswamy and Weiderpass, Elisabete},
doi = {10.1016/j.ypmed.2020.106150},
issn = {1096-0260 (Electronic)},
journal = {Preventive medicine},
keywords = {Betacoronavirus,Coronavirus Infections,Cost Savings,Cost-Benefit Analysis,Humans,Pandemics,Pneumonia, Viral,Quality-Adjusted Life Years,economics,epidemiology,prevention {\&} control},
language = {eng},
month = {sep},
pages = {106150},
pmid = {32473263},
title = {{Prevention is life- and cost-saving.}},
volume = {138},
year = {2020}
}
@article{Romeo-Arroyo2020,
abstract = {The present study provides an overview of the food related behavior of the Spanish population during the confinement period due to the Covid-19 sanitary emergency. A national survey was responded by 600 volunteers, who answered questions related to food consumption, home-food and cooking related habits (F{\&}C), and the Spanish version of the Dutch Eating Behavior Questionnaire. In general, most consumers could be considered "External eaters"; F{\&}C questionnaire allowed segmenting the population in "low-cooking engagement", "health -concerned" and "health-disregarded" groups. These consumers' segments reported different behavior, highlighting, for example, the increase of snacks and ultra-processed food consumption of the health-disregarded group.},
author = {Romeo-Arroyo, E and Mora, M and V{\'{a}}zquez-Ara{\'{u}}jo, L},
doi = {10.1016/j.ijgfs.2020.100226},
issn = {1878-4518 (Electronic)},
journal = {International journal of gastronomy and food science},
language = {eng},
month = {oct},
pages = {100226},
pmid = {32528560},
title = {{Consumer behavior in confinement times: Food choice and cooking attitudes in Spain.}},
volume = {21},
year = {2020}
}
@misc{Tang2020b,
author = {Tang, Yuanji and Serdan, Tamires D A and Masi, Laureane N and Tang, Sherry and Gorjao, Renata and Hirabara, Sandro M},
booktitle = {Emerging microbes {\&} infections},
doi = {10.1080/22221751.2020.1785337},
issn = {2222-1751 (Electronic)},
keywords = {Brazil,Coronavirus Infections,Disease Outbreaks,Epidemiologic Studies,Humans,Models, Statistical,Pandemics,Pneumonia, Viral,epidemiology},
language = {eng},
month = {dec},
number = {1},
pages = {1453--1456},
pmid = {32552473},
title = {{Epidemiology of COVID-19 in Brazil: using a mathematical model to estimate the outbreak peak and temporal evolution.}},
volume = {9},
year = {2020}
}
@misc{Ricco2020,
author = {Ricc{\`{o}}, Matteo and Ranzieri, Silvia and Balzarini, Federica and Bragazzi, Nicola Luigi and Corradi, Massimo},
booktitle = {The Science of the total environment},
doi = {10.1016/j.scitotenv.2020.139489},
issn = {1879-1026 (Electronic)},
keywords = {Air Pollutants,Air Pollution,Betacoronavirus,China,Coronavirus Infections,Humans,Pandemics,Pneumonia, Viral},
language = {eng},
month = {sep},
pages = {139489},
pmid = {32425256},
title = {{SARS-CoV-2 infection and air pollutants: Correlation or causation?}},
volume = {734},
year = {2020}
}
@article{,
doi = {10.1212/NXI.0000000000000850},
issn = {2332-7812 (Electronic)},
journal = {Neurology(R) neuroimmunology {\&} neuroinflammation},
language = {eng},
month = {sep},
number = {5},
pmid = {32646886},
title = {{Correction: Guillain-Barr{\'{e}} syndrome related to SARS-CoV-2 infection.}},
volume = {7},
year = {2020}
}
@article{Cobes2020,
abstract = {PURPOSE: The aim of this series of cases is to show the aspects of ventilation/perfusion single-photon emission computed tomography combined with computed tomography (V/Q SPECT/CT) in patients hospitalized for COVID-19 pneumonia, with the worsening of respiratory symptoms raising the suspicion of a pulmonary embolism. Patients did not benefit from CT angiography for various reasons: a contraindication, unavailability of the CT angiography, or a low clinical probability for pulmonary embolism. METHODS: We retrospectively describe the results of the V/Q SPECT/CT of five patients hospitalized for COVID-19 pneumonia in the nuclear medicine departments of the Centre Cardiologique du Nord and of the Delafontaine hospital in Saint-Denis (Ile-de-France, France) between April 2, 2020, and April 10, 2020. These patients had persistent dyspnea or chest pain suggesting pulmonary embolism. RESULTS: The V/Q SPECT/CT allowed to diagnose a pulmonary embolism in one of these five patients. We also noted several characteristics of the perfusion and ventilation depending on the lung lesions on the CT scan. The areas affected by COVID-19 were most often responsible for ventilatory anomalies with a relatively preserved perfusion. In more advanced cases of pneumonia, with alveolar fillings, the perfusion was also reduced or absent in accordance with large ventilation defects. In addition, the healthy parenchyma appeared to benefit from an uptake in ventilation and perfusion. CONCLUSION: V/Q SPECT/CT can play a role in the management of patients hospitalized for COVID-19 for the diagnosis of embolic complications with meticulous hygienic precautions. The different characteristics of the ventilatory and perfusion anomalies related to COVID-19 pneumonia will be confirmed with the next cases. In addition, in this pandemic context and facing a significant infectious risk, the utility of ventilation will also have to be specified.},
author = {Cobes, Nina and Guernou, Mohamed and Lussato, David and Queneau, Mathieu and Songy, Bernard and Bonardel, G{\'{e}}rald and Grellier, Jean-Fran{\c{c}}ois},
doi = {10.1007/s00259-020-04920-w},
issn = {1619-7089 (Electronic)},
journal = {European journal of nuclear medicine and molecular imaging},
language = {eng},
month = {sep},
number = {10},
pages = {2453--2460},
pmid = {32556400},
title = {{Ventilation/perfusion SPECT/CT findings in different lung lesions associated with COVID-19: a case series.}},
volume = {47},
year = {2020}
}
@misc{Carbone2020,
abstract = {The COVID-19 pandemic is one the biggest challenges the global community has faced this century. The threat of the virus coupled with the impacts of the social and economic shut-down measures required to slow its spread, appear to be impacting on people's mental health and wellbeing. Over the weeks, months and years ahead it is likely that many countries will experience a 'wave' of COVID-19 related mental disorders as a result of an increase in risk factors linked to the pandemic such as social isolation; unemployment; housing and income stress; intimate partner violence; work-related trauma; and grief and loss. The 'two-pronged' approach used to deal with COVID-19, provides an excellent blueprint for managing its mental health impacts as well. Nations must focus on preventing the occurrence of new-onset cases of mental disorders as well as strengthening their mental healthcare response to support people who become mentally unwell. A focus on primary prevention is particularly important to 'flatten the curve' and avoid a surge in incidence of mental disorders stemming from the COVID-19 pandemic. Evidence-based interventions designed to prevent common disorders are already available and should be scaled-up. These interventions include parenting programs, social and emotional learning programs, self-care strategies, and workplace mental wellbeing programs, among others.},
author = {Carbone, Stephen R},
booktitle = {Mental health {\&} prevention},
doi = {10.1016/j.mhp.2020.200185},
issn = {2212-6570 (Print)},
language = {eng},
month = {sep},
pages = {200185},
pmid = {32566473},
title = {{Flattening the curve of mental ill-health: the importance of primary prevention in managing the mental health impacts of COVID-19.}},
volume = {19},
year = {2020}
}
@article{Acter2020,
abstract = {According to data compiled by researchers at Johns Hopkins University in Baltimore, Maryland, more than two and half million cases of coronavirus disease 2019 (COVID-19), caused by a newly discovered virus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), have been confirmed on April 20, 2020 (Nature, 2020b). Since the emergence of this infectious disease in Asia (Wuhan, China) late last year, it has been subsequently span to every continent of the world except Antarctica (Rodr{\'{i}}guez-Morales et al., 2020). Along with a foothold in every country, the current disease pandemic is disrupting practically every aspect of life all over the world. As the outbreak are continuing to evolve, several research activities have been conducted for better understanding the origin, functions, treatments, and preventions of this novel coronavirus. This review will be a summa of the key features of novel coronavirus (nCoV), the virus causing disease 2019 and the present epidemic situation worldwide up to April 20, 2020. It is expected that this record will play an important role to take more preventive measures for overcoming the challenges faced during this current pandemic.},
author = {Acter, Thamina and Uddin, Nizam and Das, Jagotamoy and Akhter, Afroza and Choudhury, Tasrina Rabia and Kim, Sunghwan},
doi = {10.1016/j.scitotenv.2020.138996},
issn = {1879-1026 (Electronic)},
journal = {The Science of the total environment},
keywords = {Betacoronavirus,Coronavirus Infections,Global Health,Pandemics,Pneumonia, Viral},
language = {eng},
month = {aug},
pages = {138996},
pmid = {32371230},
title = {{Evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as coronavirus disease 2019 (COVID-19) pandemic: A global health emergency.}},
volume = {730},
year = {2020}
}
@article{Amoatey2020,
abstract = {Majority of countries across the globe have employed improving building ventilation, quarantine, social distancing, and disinfections as a general measure of preventing SARS-CoV-2 virus transmissions. However, arid Middle Eastern countries with hot climate (elevated outdoor temperature and humidity levels) are experiencing a different situation. Unfortunately, these harsh ambient climatic conditions in Middle Eastern countries make it impossible for most buildings to utilize natural/mechanical ventilation systems. Besides, indoor air temperatures of most buildings are very low due to overconsumption of air conditioning, thereby, it can be a potential factor of virus spread in most residential homes and public buildings. Most importantly, habitual indoor burning of incense which is the major source of coarse (PM(10); aerodynamic diameter {\textless}10 $\mu$m) and fine (PM(2.5); aerodynamic diameter {\textless}2.5 $\mu$m) particulate matters (PM) could facilitate the transmission of SARS-CoV-2 virus droplets and particles in indoor environments. In fact, it increases the spread of the virus via inhalation in these countries, especially where the wearing of masks is not regulated in public, commercial and residential buildings. It is therefore highly recommended for the relevant public health agencies to critically assess the role of poor indoor environmental conditions including the burning of incense on virus transmissions, which may help to develop control measures for the future viral outbreak effectively.},
author = {Amoatey, Patrick and Omidvarborna, Hamid and Baawain, Mahad Said and Al-Mamun, Abdullah},
doi = {10.1016/j.scitotenv.2020.139356},
issn = {1879-1026 (Electronic)},
journal = {The Science of the total environment},
keywords = {Air Conditioning,Air Pollutants,Air Pollution, Indoor,Betacoronavirus,Coronavirus Infections,Humans,Middle East,Pandemics,Particle Size,Particulate Matter,Pneumonia, Viral,Smoke,Ventilation,transmission},
language = {eng},
month = {sep},
pages = {139356},
pmid = {32416534},
title = {{Impact of building ventilation systems and habitual indoor incense burning on SARS-CoV-2 virus transmissions in Middle Eastern countries.}},
volume = {733},
year = {2020}
}
@misc{Sun2020c,
abstract = {During the proofing process, the misspelling of "additional" occurred while changing the title of the article. The complete title should be "Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Additional Benefit".},
author = {Sun, Duxin},
booktitle = {The AAPS journal},
doi = {10.1208/s12248-020-00483-8},
issn = {1550-7416 (Electronic)},
language = {eng},
month = {aug},
number = {5},
pages = {102},
pmid = {32743771},
title = {{Correction to: Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Additional Benefit.}},
volume = {22},
year = {2020}
}
@misc{Sahin2020,
author = {Sahin, Mustafa Kursat and Sahin, Gulay},
booktitle = {The European journal of general practice},
doi = {10.1080/13814788.2020.1789095},
issn = {1751-1402 (Electronic)},
keywords = {Betacoronavirus,Coronavirus Infections,Family Practice,Humans,Pandemics,Pneumonia, Viral,Turkey},
language = {eng},
month = {dec},
number = {1},
pages = {102--103},
pmid = {32674624},
title = {{Family medicine departments and healthcare centres during COVID-19 pandemic in Turkey.}},
volume = {26},
year = {2020}
}
@misc{Grimes2020,
author = {Grimes, Zachary and Bryce, Clare and Sordillo, Emilia Mia and Gordon, Ronald E and Reidy, Jason and {Paniz Mondolfi}, Alberto E and Fowkes, Mary},
booktitle = {Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology},
doi = {10.1016/j.carpath.2020.107227},
issn = {1879-1336 (Electronic)},
language = {eng},
pages = {107227},
pmid = {32718733},
title = {{Fatal Pulmonary Thromboembolism in SARS-CoV-2-Infection.}},
volume = {48},
year = {2020}
}
@misc{Fusar-Poli2020,
author = {Fusar-Poli, Paolo and Brambilla, Paolo and Solmi, Marco},
booktitle = {Journal of affective disorders},
doi = {10.1016/j.jad.2020.06.028},
issn = {1573-2517 (Electronic)},
language = {eng},
month = {oct},
pages = {78--79},
pmid = {32658828},
title = {{Learning from COVID-19 pandemic in northen italy: Impact on mental health and clinical care.}},
volume = {275},
year = {2020}
}
@article{Dexter2020,
abstract = {Reductions in perioperative surgical site infections are obtained by a multifaceted approach including patient decolonization, hand hygiene, and hub disinfection, and environmental cleaning. Associated surveillance of S. aureus transmission quantifies the effectiveness of the basic measures to prevent the transmission to patients and clinicians of pathogenic bacteria and viruses, including Coronavirus Disease 2019 (COVID-19). To measure transmission, the observational units are pairs of successive surgical cases in the same operating room on the same day. We evaluated appropriate sample sizes and strategies for measuring transmission. There was absence of serial correlation among observed counts of transmitted isolates within each of several periods (all P ≥.18). Similarly, observing transmission within or between cases of a pair did not increase the probability that the next sampled pair of cases also had observed transmission (all P ≥.23). Most pairs of cases had no detected transmitted isolates. Also, although transmission (yes/no) was associated with surgical site infection (P =.004), among cases with transmission, there was no detected dose response between counts of transmitted isolates and probability of infection (P =.25). The first of a fixed series of tests is to use the binomial test to compare the proportion of pairs of cases with S. aureus transmission to an acceptable threshold. An appropriate sample size for this screening is N =25 pairs. If significant, more samples are obtained while additional measures are implemented to reduce transmission and infections. Subsequent sampling is done to evaluate effectiveness. The two independent binomial proportions are compared using Boschloo's exact test. The total sample size for the 1(st) and 2(nd) stage is N =100 pairs. Because S. aureus transmission is invisible without testing, when choosing what population(s) to screen for surveillance, another endpoint needs to be used (e.g., infections). Only 10/298 combinations of specialty and operating room were relatively common (≥1.0{\%} of cases) and had expected incidence ≥0.20 infections per 8 hours of sampled cases. The 10 combinations encompassed ≅17{\%} of cases, showing the value of targeting surveillance of transmission to a few combinations of specialties and rooms. In conclusion, we created a sampling protocol and appropriate sample sizes for using S. aureus transmission within and between pairs of successive cases in the same operating room, the purpose being to monitor the quality of prevention of intraoperative spread of pathogenic bacteria and viruses.},
author = {Dexter, Franklin and Ledolter, Johannes and Wall, Russell T and Datta, Subhradeep and Loftus, Randy W},
doi = {10.1016/j.pcorm.2020.100115},
issn = {2405-6030 (Electronic)},
journal = {Perioperative care and operating room management},
language = {eng},
month = {sep},
pages = {100115},
pmid = {32501426},
title = {{Sample sizes for surveillance of S. aureus transmission to monitor effectiveness and provide feedback on intraoperative infection control including for COVID-19.}},
volume = {20},
year = {2020}
}
@article{Kerimray2020,
abstract = {Number of cities worlwide experienced air quality improvements during COVID-19 lockdowns; however, such changes may have been different in places with major contributions from nontraffic related sources. In Almaty, a city-scale quarantine came into force on March 19, 2020, which was a week after the first COVID-19 case was registered in Kazakhstan. This study aims to analyze the effect of the lockdown from March 19 to April 14, 2020 (27 days), on the concentrations of air pollutants in Almaty. Daily concentrations of PM(2.5), NO(2), SO(2), CO, O(3), and BTEX were compared between the periods before and during the lockdown. During the lockdown, the PM(2.5) concentration was reduced by 21{\%} with spatial variations of 6-34{\%} compared to the average on the same days in 2018-2019, and still, it exceeded WHO daily limit values for 18 days. There were also substantial reductions in CO and NO(2) concentrations by 49{\%} and 35{\%}, respectively, but an increase in O(3) levels by 15{\%} compared to the prior 17 days before the lockdown. The concentrations of benzene and toluene were 2-3 times higher than those during in the same seasons of 2015-2019. The temporal reductions may not be directly attributed to the lockdown due to favorable meteorological variations during the period, but the spatial effects of the quarantine on the pollution levels are evidenced. The results demonstrate the impact of traffic on the complex nature of air pollution in Almaty, which is substantially contributed by various nontraffic related sources, mainly coal-fired combined heat and power plants and household heating systems, as well as possible small irregular sources such as garbage burning and bathhouses.},
author = {Kerimray, Aiymgul and Baimatova, Nassiba and Ibragimova, Olga P and Bukenov, Bauyrzhan and Kenessov, Bulat and Plotitsyn, Pavel and Karaca, Ferhat},
doi = {10.1016/j.scitotenv.2020.139179},
issn = {1879-1026 (Electronic)},
journal = {The Science of the total environment},
keywords = {Air Pollutants,Air Pollution,Betacoronavirus,Cities,Coronavirus Infections,Environmental Monitoring,Kazakhstan,Pandemics,Particulate Matter,Pneumonia, Viral},
language = {eng},
month = {aug},
pages = {139179},
pmid = {32387822},
title = {{Assessing air quality changes in large cities during COVID-19 lockdowns: The impacts of traffic-free urban conditions in Almaty, Kazakhstan.}},
volume = {730},
year = {2020}
}
@misc{Ali2020,
author = {Ali, Hatem and Daoud, Ahmed and Mohamed, Mahmoud M and Salim, Sohail Abdul and Yessayan, Lenar and Baharani, Jyoti and Murtaza, Asam and Rao, Vinaya and Soliman, Karim M},
booktitle = {Renal failure},
doi = {10.1080/0886022X.2020.1756323},
issn = {1525-6049 (Electronic)},
keywords = {Acute Kidney Injury,Betacoronavirus,Coronavirus Infections,Humans,Pandemics,Pneumonia, Viral,Renal Replacement Therapy,Survival Rate,complications,mortality,therapy},
language = {eng},
month = {nov},
number = {1},
pages = {393--397},
pmid = {32340507},
title = {{Survival rate in acute kidney injury superimposed COVID-19 patients: a systematic review and meta-analysis.}},
volume = {42},
year = {2020}
}
@misc{Buioni2020,
author = {Buioni, Dario and Nardi, Paolo and Ruvolo, Giovanni},
booktitle = {Clinica chimica acta; international journal of clinical chemistry},
doi = {10.1016/j.cca.2020.05.031},
issn = {1873-3492 (Electronic)},
keywords = {Anticoagulants,Betacoronavirus,Blood Coagulation Disorders,Cardiovascular Diseases,Coronavirus,Coronavirus Infections,Humans,Pandemics,Pneumonia, Viral,Thrombocytopenia},
language = {eng},
month = {sep},
pages = {109},
pmid = {32417209},
title = {{Thrombocytopenia and coagulation disorders due to COVID 19 infection with concomitant cardiovascular diseases requiring anti-platelet and anticoagulant therapy, which strategy?}},
volume = {508},
year = {2020}
}
@misc{Papa-Gobbi2020,
abstract = {Coronavirus disease 2019 (COVID-19) pandemic has become one of the most challenging episodes in the history of modern public health, with particular emphasis in high risk population. However, the evidence regarding their response to the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2), the agent responsible for COVID-19 is scant (2) . Herein we present the clinical and therapeutic course of a SARS-CoV-2 infection in a patient with multivisceral transplant and a recent tuberculosis infection.},
author = {Papa-Gobbi, Rodrigo and Bueno, Alba and Serradilla, Javier and Talayero, Paloma and Stringa, Pablo and Pascual-Miguel, B{\'{a}}rbara and Alcolea-S{\'{a}}nchez, Alida and Gonz{\'{a}}lez-Sacristan, Roc{\'{i}}o and Andr{\'{e}}s, Ane M and L{\'{o}}pez-Santamar{\'{i}}a, Manuel and Rumbo, Mart{\'{i}}n and Ramos-Boluda, Esther and Hern{\'{a}}ndez-Oliveros, Francisco},
booktitle = {Transplant infectious disease : an official journal of the Transplantation Society},
doi = {10.1111/tid.13430},
issn = {1399-3062 (Electronic)},
language = {eng},
month = {aug},
pages = {e13430},
pmid = {32741047},
title = {{Novel coronavirus (SARS-CoV-2) infection in a patient with multivisceral transplant.}},
year = {2020}
}
@article{Gebbia2020,
abstract = {To contain COVID-19 spread, Italy is under a global lockdown since February 21, 2020, except for health services and food supply. In this scenario, growing apprehension concerning legal consequences is rising among health professionals due to several ethical and legal questions. Even if medical ethicists may approve patients' prioritization protocols, hospitals and health professionals remain highly exposed to liability. The so-called smart-working may be very useful, but it may harbor potential legal harms for health personnel and patients and safety. Moreover, personal umbrella policies also often exclude liability arising out of the transmission of a communicable disease, especially a pandemic state, is declared. Under the pressure of medical associations, Italian Government political forces have very recently presented an amendment to the recently released ordinances for the COVID-19 emergency aimed to reduce medical liability. Presumably, similar epidemics or other wide-scale similar events may happen again in an unpredictable future. Therefore, more articulated legal regulations are strongly needed starting from lessons learned from this epidemic.},
author = {Gebbia, Vittorio and Bordonaro, Roberto and Blasi, Livio and Piazza, Dario and Pellegrino, Alessandro and Iacono, Carmelo and Spada, Massimiliano and Tralongo, Paolo and Firenze, Alberto},
doi = {10.1016/j.jcpo.2020.100234},
issn = {2213-5383 (Print)},
journal = {Journal of cancer policy},
language = {eng},
month = {sep},
pages = {100234},
pmid = {32562478},
title = {{Liability of clinical oncologists and the COVID-19 emergency: Between hopes and concerns.}},
volume = {25},
year = {2020}
}
@misc{Nasim2020,
author = {Nasim, Sundus and Hashmi, Shariq Haider and Azim, Dua and Kumar, Sohail and Nasim, Jasia},
booktitle = {Infectious diseases (London, England)},
doi = {10.1080/23744235.2020.1780307},
issn = {2374-4243 (Electronic)},
keywords = {Antibodies, Monoclonal, Humanized,Betacoronavirus,Coronavirus Infections,Disease Progression,Humans,Pandemics,Pneumonia, Viral,Retrospective Studies,Risk Factors},
language = {eng},
month = {sep},
number = {9},
pages = {681--682},
pmid = {32644027},
title = {{Tocilizumab for COVID-19: a real 'miracle drug'?}},
volume = {52},
year = {2020}
}
@article{Mponponsuo2020,
author = {Mponponsuo, Kwadwo and Kerkerian, Genevi{\`{e}}ve and Somayaji, Ranjani and Missaghi, Bayan and Vayalumkal, Joseph V and Larios, Oscar E and Berenger, Byron M and Lauzon, Matt and McDonnell, Nicole and Conly, John},
doi = {10.1017/ice.2020.392},
issn = {1559-6834 (Electronic)},
journal = {Infection control and hospital epidemiology},
language = {eng},
month = {aug},
pages = {1--11},
pmid = {32741398},
title = {{Lack of Nosocomial Transmission to Exposed Inpatients and Co-Workers in an Investigation of Five SARS-CoV-2 Infected Healthcare Workers.}},
year = {2020}
}
@article{Wood2020,
abstract = {Managing healthcare demand and capacity is especially difficult in the context of the COVID-19 pandemic, where limited intensive care resources can be overwhelmed by a large number of cases requiring admission in a short space of time. If patients are unable to access this specialist resource, then death is a likely outcome. In appreciating these 'capacity-dependent' deaths, this paper reports on the clinically-led development of a stochastic discrete event simulation model designed to capture the key dynamics of the intensive care admissions process for COVID-19 patients. With application to a large public hospital in England during an early stage of the pandemic, the purpose of this study was to estimate the extent to which such capacity-dependent deaths can be mitigated through demand-side initiatives involving non-pharmaceutical interventions and supply-side measures to increase surge capacity. Based on information available at the time, results suggest that total capacity-dependent deaths can be reduced by 75{\%} through a combination of increasing capacity from 45 to 100 beds, reducing length of stay by 25{\%}, and flattening the peak demand to 26 admissions per day. Accounting for the additional 'capacity-independent' deaths, which occur even when appropriate care is available within the intensive care setting, yields an aggregate reduction in total deaths of 30{\%}. The modelling tool, which is freely available and open source, has since been used to support COVID-19 response planning at a number of healthcare systems within the UK National Health Service.},
author = {Wood, Richard M and McWilliams, Christopher J and Thomas, Matthew J and Bourdeaux, Christopher P and Vasilakis, Christos},
doi = {10.1007/s10729-020-09511-7},
issn = {1386-9620 (Print)},
journal = {Health care management science},
language = {eng},
month = {sep},
number = {3},
pages = {315--324},
pmid = {32642878},
title = {{COVID-19 scenario modelling for the mitigation of capacity-dependent deaths in intensive care.}},
volume = {23},
year = {2020}
}
@article{Raymond-Hayling2020,
author = {Raymond-Hayling, Olivia},
doi = {10.1080/10872981.2020.1781749},
issn = {1087-2981 (Electronic)},
journal = {Medical education online},
language = {eng},
month = {dec},
number = {1},
pages = {1781749},
pmid = {32544000},
title = {{What lies in the year ahead for medical education? A medical student's perspective during the COVID-19 pandemic.}},
volume = {25},
year = {2020}
}
@misc{Fragiel2020,
author = {Fragiel, M and {Canora Lebrato}, J and Candel, F J and {Zapatero Gaviria}, A and {Marco Mart{\'{i}}nez}, J and {Gonz{\'{a}}lez Del Castillo}, J},
booktitle = {Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia},
doi = {10.37201/req/058.2020},
issn = {1988-9518 (Electronic)},
language = {spa},
month = {aug},
pmid = {32741193},
title = {{[Differential diagnosis of pneumonia at the time of COVID-19].}},
year = {2020}
}
@article{Du2020,
abstract = {Since its outbreak in Wuhan, Hubei Province China, 2019-coronavirus infected disease (COVID-19) had been widely spread all over the world, the control of which calls for a better understanding of its epidemiology and clinical characteristics. We included 12 confirmed cases of COVID-19 in First Affiliated Hospital of Jilin University from 23 January 2020 to 11 February 2020, which were retrospectively analyzed for epidemiological, demographic, clinical, laboratory, and radiological features. All the patients were confirmed by nucleic acid detection, the average age of whom was 45.25 years (range, 23-79 years). Most patients had a history of Wuhan traveling or had contact with Wuhan travelers or infected cases. Obvious family cluster was observed. Clinical manifestations included fever (12/12), fatigue (10/12), cough (6/12), sore throat (4/12), headache (3/12), and diarrhea (2/12). Only three out of eight patients had pneumonia manifestation on radiography. Most patients had a normal white blood cell (WBC) count and normal or reduced lymphocyte (LY) count. Pneumonia changes were observed in all the four patients who underwent a chest CT scan. Only one elderly patient developed severe pneumonia, while all the rest were mild disease and had a self-limiting course.},
author = {Du, Na and Chen, Haiying and Zhang, Qing and Che, Lihe and Lou, Lixin and Li, Xiaohua and Zhang, Kaiyu and Bao, Wanguo},
doi = {10.1080/21505594.2020.1767357},
issn = {2150-5608 (Electronic)},
journal = {Virulence},
keywords = {Adult,Aged,Betacoronavirus,China,Coronavirus Infections,Cough,Diarrhea,Fatigue,Female,Fever,Headache,Humans,Leukocyte Count,Male,Middle Aged,Pandemics,Pharyngitis,Pneumonia, Viral,Retrospective Studies,Tomography, X-Ray Computed,Young Adult,diagnostic imaging,epidemiology,etiology,isolation {\&} purification,pathology,virology},
language = {eng},
month = {dec},
number = {1},
pages = {482--485},
pmid = {32441574},
title = {{A case series describing the epidemiology and clinical characteristics of COVID-19 infection in Jilin Province.}},
volume = {11},
year = {2020}
}
@article{Chen2020e,
abstract = {Since December 2019, an increasing number of cases associated with the 2019 novel coronavirus (2019‑nCoV) have emerged in Wuhan, China, which has resulted in a rapid outbreak in China and worldwide. The present study aimed to describe the clinical, laboratory and radiological characteristics of 2019‑nCoV pneumonia (NCP) in Zhejiang province, outside of Wuhan. A total of 74 patients with 2019‑nCoV were continuously enrolled between January 22 and March 2, 2020 at Zhejiang Hospital. Diagnosis was confirmed at Zhejiang Hospital by reverse transcription‑PCR (RT‑PCR), which was approved by the Chinese government. Subsequently, the clinical features between positive‑ and negative‑NCP patients in Zhejiang were compared. Among the 74 hospitalized patients with suspected 2019‑NCP, six patients (one male and five female patients) were confirmed to be infected with 2019‑nCoV by RT‑PCR. The average age of the confirmed patients was 40±13 years. There were three family clusters among the confirmed cases, one patient from each of these families had travel history or contact with patients from Wuhan within 2 weeks. Compared with non‑NCP patients, the most common symptoms at onset for patients with NCP were fever (5/6; 83.3{\%}) and cough (5/6; 83.3{\%}), followed by dyspnea/pharyngalgia (2/6; 33.3{\%}), whereas myalgia (1/6; 16.7{\%}) and fatigue (1/6; 16.7{\%}) were less common. All 74 patients with suspected NCP exhibited abnormal computerized tomography (CT) images. In total, 2/6 (33.3{\%}) patients with confirmed NCP presented with bilateral pneumonia, and 21/68 (30.9{\%}) non‑NCP patients exhibited bilateral pneumonia, with bilateral distribution of patchy shadows or ground glass opacity. The present study revealed that epidemiological history was critical to the diagnosis of 2019‑nCoV in low epidemic regions outside Hubei province. It was also identified that chest CT could not replace nucleic acid testing due to similar radiological manifestations.},
author = {Chen, Ling and Jin, Qiuhong and Zhou, Ying and Yang, Jiao and Wang, Zhehua and Ge, Ke and Yang, Jiangle and Wang, Hong},
doi = {10.3892/mmr.2020.11329},
issn = {1791-3004 (Electronic)},
journal = {Molecular medicine reports},
language = {eng},
month = {sep},
number = {3},
pages = {2583--2587},
pmid = {32705222},
title = {{Clinical characteristics of 2019 novel coronavirus pneumonia in Zhejiang province, China.}},
volume = {22},
year = {2020}
}
@article{Li2020,
abstract = {In December 2019, Wuhan, China suffered a serious outbreak of a novel coronavirus infectious disease (COVID) caused by novel severe acute respiratory syndrome-related coronavirus (SARS-CoV 2). To quickly identify the pathogen, we designed and screened primer sets, and established a sensitive and specific qRT-PCR assay for SARS-CoV 2; the lower limit of detection (LOD) was 14.8 (95{\%} CI: 9.8-21) copies per reaction. We combined this qRT-PCR assay with an automatic integration system for nucleic acid extraction and amplification, thereby establishing an automatic integrated gene detection system (AIGS) for SARS-CoV 2. Cross reactive analysis performed in 20 other respiratory viruses and 37 nasopharyngeal swabs confirmed a 100{\%} specificity of the assay. Using two fold diluted SARS-CoV 2 culture, the LOD of AIGS was confirmed to be 365 copies/ml (95{\%} CI: 351-375), which was Comparable to that of conventional q RT-PCR (740 copies/ml, 95{\%} CI: 689-750). Clinical performances of AIGS assay were assessed in 266 suspected COVID-19 clinical respiratory tract samples tested in parallel with a commercial kit. The clinical sensitivity of the AIGS test was 97.62{\%} (95{\%} CI: 0.9320-0.9951) based on the commercial kit test result, and concordance analysis showed a high agreement in SARS-CoV-2 detection between the two assays, Pearson R was 0.9623 (95{\%} CI: 0.9523-0.9703). The results indicated that this AIGS could be used for rapid detection of SARS-CoV 2. With the advantage of simple operation and less time consuming, AIGS could be suitable for SARS-CoV2 detection in primary medical institutions, thus would do a great help to improve detection efficiency and control the spread of COVID-19.},
author = {Li, Yuchang and Li, Jing and Zhang, Ying and Dai, Lizhong and Li, Lin and Liu, Juan and Zhang, Sen and Wu, Xiaoyan and Hu, Yi and Qin, Chenfeng and Jiang, Tao and Kang, Xiaoping},
doi = {10.1080/22221751.2020.1782774},
issn = {2222-1751 (Electronic)},
journal = {Emerging microbes {\&} infections},
keywords = {Automation, Laboratory,Betacoronavirus,China,Coronavirus Infections,DNA Primers,Humans,Limit of Detection,Pandemics,Pneumonia, Viral,RNA, Viral,Real-Time Polymerase Chain Reaction,Sensitivity and Specificity,Virus Cultivation,analysis,diagnosis,isolation {\&} purification,methods},
language = {eng},
month = {dec},
number = {1},
pages = {1489--1496},
pmid = {32543298},
title = {{Development of an automatic integrated gene detection system for novel severe acute respiratory syndrome-related coronavirus (SARS-CoV2).}},
volume = {9},
year = {2020}
}
@misc{Kumar2020a,
author = {Kumar, Amarjeet and Kumar, Ajeet and Kumar, Neeraj and Sinha, Chandni and Kumar, Abhyuday},
booktitle = {Journal of clinical anesthesia},
doi = {10.1016/j.jclinane.2020.109869},
issn = {1873-4529 (Electronic)},
keywords = {Aerosols,Anesthesiologists,Anesthesiology,Betacoronavirus,Coronavirus,Coronavirus Infections,Humans,Pandemics,Pneumonia, Viral},
language = {eng},
month = {oct},
pages = {109869},
pmid = {32417619},
title = {{Transportation of intubated COVID-19 patients: Bain circuit with underwater seal system is an option to prevent aerosol transmission.}},
volume = {65},
year = {2020}
}
@article{Chan2020,
abstract = {The ensuing COVID-19 pandemic poses unprecedented and daunting challenges to the routine delivery of oncological and supportive care to patients with breast cancer. Considerations include the infective risk of patients who are inherently immunosuppressed from their malignancy and therapies, long-term oncological outcomes from the treatment decisions undertaken during this extraordinary period, and diverted healthcare resources to support a coordinated whole-of-society outbreak response. In this review, we chronicle the repercussions of the COVID-19 outbreak on breast cancer management in Singapore and describe our approach to triaging and prioritising care of breast tumours. We further propose adaptations to established clinical processes and practices across the different specialties involved in breast oncology, with references to the relevant evidence base or expert consensus guidelines. These recommendations have been developed within the unique context of Singapore's public healthcare sector. They can serve as a resource to guide breast cancer management for future contingencies in this city-state, while certain elements therein may be extrapolatable to other medical systems during this global public health emergency.},
author = {Chan, Jack Junjie and Sim, Yirong and Ow, Samuel Guan Wei and Lim, Joline Si Jing and Kusumawidjaja, Grace and Zhuang, Qingyuan and Wong, Ru Xin and Wong, Fuh Yong and Tan, Veronique Kiak Mien and Tan, Tira Jing Ying},
doi = {10.1530/ERC-20-0157},
issn = {1479-6821 (Electronic)},
journal = {Endocrine-related cancer},
language = {eng},
month = {sep},
number = {9},
pages = {R307--R327},
pmid = {32544879},
title = {{The impact of COVID-19 on and recommendations for breast cancer care: the Singapore experience.}},
volume = {27},
year = {2020}
}
@misc{Zhang2020b,
abstract = {Since Dec 2019, China has experienced an outbreak caused by a novel coronavirus, 2019-nCoV. A travel ban was implemented for Wuhan, Hubei on Jan 23 to slow down the outbreak. We found a significant positive correlation between population influx from Wuhan and confirmed cases in other cities across China (R(2) = 0.85, P {\textless} 0.001), especially cities in Hubei (R(2) = 0.88, P {\textless} 0.001). Removing the travel restriction would have increased 118{\%} (91{\%}-172{\%}) of the overall cases for the coming week, and a travel ban taken three days or a week earlier would have reduced 47{\%} (26{\%}-58{\%}) and 83{\%} (78{\%}-89{\%}) of the early cases. We would expect a 61{\%} (48{\%}-92{\%}) increase of overall cumulative cases without any restrictions on returning residents, and 11{\%} (8{\%}-16{\%}) increase if the travel ban stays in place for Hubei. Cities from Yangtze River Delta, Pearl River Delta, and Capital Economic Circle regions are at higher risk.},
author = {Zhang, Chi and Chen, Cai and Shen, Wei and Tang, Feng and Lei, Hao and Xie, Yu and Cao, Zicheng and Tang, Kang and Bai, Junbo and Xiao, Lehan and Xu, Yutian and Song, Yanxin and Chen, Jiwei and Guo, Zhihui and Guo, Yichen and Wang, Xiao and Xu, Modi and Zou, Huachun and Shu, Yuelong and Du, Xiangjun},
booktitle = {Emerging microbes {\&} infections},
doi = {10.1080/22221751.2020.1760143},
issn = {2222-1751 (Electronic)},
keywords = {Betacoronavirus,China,Coronavirus Infections,Humans,Pandemics,Pneumonia, Viral,Travel,epidemiology,isolation {\&} purification,legislation {\&} jurisprudence,statistics {\&} numerical data,transmission},
language = {eng},
month = {dec},
number = {1},
pages = {988--990},
pmid = {32321369},
title = {{Impact of population movement on the spread of 2019-nCoV in China.}},
volume = {9},
year = {2020}
}
@misc{Su2020b,
author = {Su, Zheng},
booktitle = {Contemporary clinical trials communications},
doi = {10.1016/j.conctc.2020.100581},
issn = {2451-8654 (Electronic)},
language = {eng},
month = {sep},
pages = {100581},
pmid = {32537526},
title = {{The critical role of futility analysis in the pursuit of effective treatments for COVID-19.}},
volume = {19},
year = {2020}
}
@article{Cai2020,
abstract = {BACKGROUND AND OBJECTIVE: Coronavirus disease 2019 (COVID-19) is a new infectious disease with high transmissibility and morbidity. It has caused substantial mental distress to medical professionals. We aimed to compare the psychological impact of the COVID-19 outbreak between frontline and non-frontline medical workers in China. METHODS: This case-control study recruited 1173 frontline and 1173 age- and sex-matched non-frontline medical workers during the COVID-19 outbreak (February 11 to 26, 2020). A set of online questionnaires were used to measure mental problems (i.e., anxiety, insomnia, and depressive symptoms), and help-seeking behavior and treatment for these mental problems. RESULTS: Frontline medical workers had higher rates of any mental problem (52.6{\%} vs. 34.0{\%}, adjusted OR=1.88, 95{\%} CI=1.57-2.25), anxiety symptoms (15.7{\%} vs. 7.4{\%}, adjusted OR=1.95, 95{\%} CI=1.46-2.61), depressed mood (marginally insignificant; 14.3{\%} vs. 10.1{\%}, adjusted OR=1.32, 95{\%} CI=0.99-1.76) and insomnia (47.8{\%} vs. 29.1{\%}, adjusted OR=1.96, 95{\%} CI=1.63-2.36) than non-frontline medical workers. No significant difference was observed in terms of suicidal ideation (12.0{\%} vs. 9.0{\%}, adjusted OR=1.25, 95{\%} CI=0.92-1.71), help-seeking (4.5{\%} vs. 4.5{\%}, adjusted OR=1.00, 95{\%} CI=0.53-1.87) or treatment (3.4{\%} vs. 2.3{\%}, adjusted OR=1.38, 95{\%} CI=0.54-3.52) for mental problems. LIMITATIONS: The case-control nature of the data precludes causal inferences, and there is a possibility of bias related to self-reports. CONCLUSIONS: Frontline medical workers had more mental problems but comparable help-seeking behaviors and treatment for these problems than non-frontline medical workers. These findings highlight the timely mental support and intervention for medical workers, especially for those on the frontline.},
author = {Cai, Qi and Feng, Hongliang and Huang, Jing and Wang, Meiyao and Wang, Qunfeng and Lu, Xuanzhen and Xie, Yu and Wang, Xing and Liu, Zhenxing and Hou, Botong and Ouyang, Keni and Pan, Jing and Li, Qin and Fu, Beibei and Deng, Yongchao and Liu, Yumin},
doi = {10.1016/j.jad.2020.06.031},
issn = {1573-2517 (Electronic)},
journal = {Journal of affective disorders},
language = {eng},
month = {oct},
pages = {210--215},
pmid = {32734910},
title = {{The mental health of frontline and non-frontline medical workers during the coronavirus disease 2019 (COVID-19) outbreak in China: A case-control study.}},
volume = {275},
year = {2020}
}
@article{Pasin2020,
author = {Pasin, Laura and Sella, Nicol{\`{o}} and Correale, Christelle and Boscolo, Annalisa and Rosi, Paolo and Saia, Mario and Mantoan, Domenico and Navalesi, Paolo},
doi = {10.1053/j.jvca.2020.05.005},
issn = {1532-8422 (Electronic)},
journal = {Journal of cardiothoracic and vascular anesthesia},
language = {eng},
month = {sep},
number = {9},
pages = {2341--2345},
pmid = {32425461},
title = {{Regional COVID-19 Network for Coordination of SARS-CoV-2 outbreak in Veneto, Italy.}},
volume = {34},
year = {2020}
}
@article{Patel2020,
abstract = {Severe acute respiratory syndrome coronavirus (SARS-CoV-2) known as COVID-19 has emerged as a major threat to human existence. COVID-19 seems to have undergone adaptive evolution through an intermediate host, most likely bats. The flu leads to severe pneumonia that causes respiratory and multi-organ failure. The absence of any known treatment procedures, drugs, or vaccines has created panic around the World. The need is to develop rapid testing kits, drugs and vaccines. However, these proposals are time-consuming processes. At present social distancing along with previously known traditional medicines can act as quick and short-term alternatives for treating this viral flu.},
author = {Patel, Sanjay K S and Lee, Jung-Kul and Kalia, Vipin C},
doi = {10.1007/s12088-020-00893-4},
issn = {0046-8991 (Print)},
journal = {Indian journal of microbiology},
language = {eng},
month = {sep},
number = {3},
pages = {263--268},
pmid = {32647390},
title = {{Deploying Biomolecules as Anti-COVID-19 Agents.}},
volume = {60},
year = {2020}
}
@article{Ladha2020,
abstract = {Coronavirus disease (COVID-19) chilblains is a well-reported cutaneous pattern of severe acute respiratory syndrome coronavirus (SARS-CoV-2). Through this narrative review, we provide an evidence-based overview of idiopathic and secondary chilblains, distinguishing features of COVID-19 chilblains, and a systematic clinical approach to history, examination, investigations, and treatment. In the absence of cold or damp exposure, COVID-19 should be considered as a cause of acute chilblains. The timing of onset of COVID-19 chilblains relative to active SARS-CoV-2 viremia remains unclear. Patients with suspected COVID-19 chilblains should thus follow public health guidelines for COVID-19 testing and self-isolation.},
author = {Ladha, Malika A and Luca, Nadia and Constantinescu, Cora and Naert, Karen and Ramien, Michele L},
doi = {10.1177/1203475420937978},
issn = {1615-7109 (Electronic)},
journal = {Journal of cutaneous medicine and surgery},
language = {eng},
month = {aug},
pages = {1203475420937978},
pmid = {32741218},
title = {{Approach to Chilblains During the COVID-19 Pandemic.}},
year = {2020}
}
@article{Wang2020b,
author = {Wang, Wei and Zhang, Qing and Qu, Fan},
doi = {10.1016/j.imr.2020.100461},
issn = {2213-4220 (Print)},
journal = {Integrative medicine research},
language = {eng},
month = {sep},
number = {3},
pages = {100461},
pmid = {32704474},
title = {{The potential benefits of Chinese integrative medicine for pregnancy women during the COVID-19 pandemic.}},
volume = {9},
year = {2020}
}
@article{Gurung2020,
abstract = {A new SARS coronavirus (SARS-CoV-2) belonging to the genus Betacoronavirus has caused a pandemic known as COVID-19. Among coronaviruses, the main protease (M(pro)) is an essential drug target which, along with papain-like proteases catalyzes the processing of polyproteins translated from viral RNA and recognizes specific cleavage sites. There are no human proteases with similar cleavage specificity and therefore, inhibitors are highly likely to be nontoxic. Therefore, targeting the SARS-CoV-2 M(pro) enzyme with small molecules can block viral replication. The present study is aimed at the identification of promising lead molecules for SARS-CoV-2 M(pro) enzyme through virtual screening of antiviral compounds from plants. The binding affinity of selected small drug-like molecules to SARS-CoV-2 M(pro), SARS-CoV M(pro) and MERS-CoV M(pro) were studied using molecular docking. Bonducellpin D was identified as the best lead molecule which shows higher binding affinity (-9.28 kcal/mol) as compared to the control (-8.24 kcal/mol). The molecular binding was stabilized through four hydrogen bonds with Glu166 and Thr190 as well as hydrophobic interactions via eight residues. The SARS-CoV-2 M(pro) shows identities of 96.08{\%} and 50.65{\%} to that of SARS-CoV M(pro) and MERS-CoV M(pro) respectively at the sequence level. At the structural level, the root mean square deviation (RMSD) between SARS-CoV-2 M(pro) and SARS-CoV M(pro) was found to be 0.517 {\AA} and 0.817 {\AA} between SARS-CoV-2 M(pro) and MERS-CoV M(pro). Bonducellpin D exhibited broad-spectrum inhibition potential against SARS-CoV M(pro) and MERS-CoV M(pro) and therefore is a promising drug candidate, which needs further validations through in vitro and in vivo studies.},
author = {Gurung, Arun Bahadur and Ali, Mohammad Ajmal and Lee, Joongku and Farah, Mohammad Abul and Al-Anazi, Khalid Mashay},
doi = {10.1016/j.lfs.2020.117831},
issn = {1879-0631 (Electronic)},
journal = {Life sciences},
keywords = {Amino Acid Sequence,Antiviral Agents,Betacoronavirus,Binding Sites,Computer Simulation,Coronavirus Infections,Cysteine Endopeptidases,Drug Evaluation, Preclinical,Humans,Molecular Docking Simulation,Pandemics,Plant Extracts,Pneumonia, Viral,Protease Inhibitors,Protein Binding,Small Molecule Libraries,Viral Nonstructural Proteins,Virus Replication,antagonists {\&} inhibitors,chemistry,drug effects,drug therapy,enzymology,epidemiology,metabolism,methods,pharmacology,virology},
language = {eng},
month = {aug},
pages = {117831},
pmid = {32450166},
title = {{Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 M(pro) enzyme through in silico approach.}},
volume = {255},
year = {2020}
}
@misc{Abdullah2020a,
author = {Abdullah, Muhammad Syafiq and Chong, Pui Lin and Asli, Rosmonaliza and Momin, Riamiza Natalie and Mani, Babu Ivan and Metussin, Dhiya and Chong, Vui Heng},
booktitle = {Infectious diseases (London, England)},
doi = {10.1080/23744235.2020.1780309},
issn = {2374-4243 (Electronic)},
keywords = {Aftercare,Betacoronavirus,Coronavirus Infections,Humans,Negative Results,Pandemics,Patient Discharge,Pneumonia, Viral,Reverse Transcriptase Polymerase Chain Reaction},
language = {eng},
month = {oct},
number = {10},
pages = {743--745},
pmid = {32579420},
title = {{Post discharge positive re-tests in COVID-19: common but clinically non-significant.}},
volume = {52},
year = {2020}
}
@article{Herman2020,
abstract = {• Pre-hospital COVID-19 screening should be implemented for all pregnant patients. • Limit the number of staff in a delivery room or operating room when feasible. • Encourage the use of video messaging with other members of the patient's support system. • An experienced provider should perform neuraxial procedures and intubations, whenever possible.},
author = {Herman, Jared A and Urits, Ivan and Kaye, Alan D and Urman, Richard D and Viswanath, Omar},
doi = {10.1016/j.jclinane.2020.109860},
issn = {1873-4529 (Electronic)},
journal = {Journal of clinical anesthesia},
language = {eng},
month = {oct},
pages = {109860},
pmid = {32417620},
title = {{COVID-19: Obstetric anesthesia care considerations.}},
volume = {65},
year = {2020}
}
@article{Kastritis2020,
abstract = {As of June 10th 2020 about 7.2 million individuals have tested positive for, and more than 410,000 have died due to COVID-19. In this review we outline the pathophysiology that underpins the potential use of anti-rheumatic therapies for severe COVID-19 infection and summarize the current evidence regarding the risk and outcome of COVID-19 in patients with systemic autoimmune diseases. Thus far there is no convincing evidence that any disease-modifying anti-rheumatic drug (conventional synthetic, biologic or targeted synthetic) including hydroxychloroquine, may protect against severe COVID-19 infection; answers about their possible usefulness in the management of the cytokine storm associated with severe COVID-9 infection will only arise from ongoing randomized controlled trials. Evidence on COVID-19 risk and outcome in patients with systemic autoimmune diseases is extremely limited; thus, any conclusions would be unsafe and should be seen with great caution. At present, the risk and severity (hospitalization, intensive care unit admission and death) of COVID-19 infection in people with autoimmune diseases do not appear particularly dissimilar to the general population, with the possible exception of hospitalization in patients exposed to high glucocorticoid doses. At this stage it is impossible to draw any conclusions for differences in COVID-19 risk and outcome between different autoimmune diseases and between the various immunomodulatory therapies used for them. More research in the field is obviously required, including as a minimum careful and systematic epidemiology and appropriately controlled clinical trials.},
author = {Kastritis, Efstathios and Kitas, George D and Vassilopoulos, Dimitrios and Giannopoulos, Georgios and Dimopoulos, Meletios A and Sfikakis, Petros P},
doi = {10.1007/s00296-020-04629-x},
issn = {1437-160X (Electronic)},
journal = {Rheumatology international},
keywords = {Antibodies, Monoclonal, Humanized,Antirheumatic Agents,Autoimmune Diseases,Betacoronavirus,Comorbidity,Coronavirus Infections,Cytokine Release Syndrome,Humans,Janus Kinase Inhibitors,Pandemics,Pneumonia, Viral,Risk Factors,Severity of Illness Index,Tumor Necrosis Factor Inhibitors,drug therapy,epidemiology,immunology,therapeutic use},
language = {eng},
month = {sep},
number = {9},
pages = {1353--1360},
pmid = {32654078},
title = {{Systemic autoimmune diseases, anti-rheumatic therapies, COVID-19 infection risk and patient outcomes.}},
volume = {40},
year = {2020}
}
@article{Liu2020d,
abstract = {This study aimed to estimate the attack rates, and identify the risk factors of COVID-19 infection. Based on a retrospective cohort study, we investigated 11,580 contacts of COVID-19 cases in Guangdong Province from 10 January to 15 March 2020. All contacts were tested by RT-PCR to detect their infection of SARS-COV-2. Attack rates by characteristics were calculated. Logistic regression was used to estimate the risk factors of infection for COVID-19. A total of 515 of 11,580 contacts were identified to be infected with SARS-COV-2. Compared to young adults aged 20-29 years, the infected risk was higher in children (RR: 2.59, 95{\%}CI: 1.79-3.76), and old people aged 60-69 years (RR: 5.29, 95{\%}CI: 3.76-7.46). Females also had higher infected risk (RR: 1.66, 95{\%}CI: 1.39-2.00). People having close relationship with index cases encountered higher infected risk (RR for spouse: 20.68, 95{\%}CI: 14.28-29.95; RR for non-spouse family members: 9.55, 95{\%}CI: 6.73-13.55; RR for close relatives: 5.90, 95{\%}CI: 4.06-8.59). Moreover, contacts exposed to index case in symptomatic period (RR: 2.15, 95{\%}CI: 1.67-2.79), with critically severe symptoms (RR: 1.61, 95{\%}CI: 1.00-2.57), with symptoms of dizzy (RR: 1.58, 95{\%}CI: 1.08-2.30), myalgia (RR: 1.49, 95{\%}CI: 1.15-1.94), and chill (RR: 1.42, 95{\%}CI: 1.05-1.92) had higher infected risks. Children, old people, females, and family members are susceptible of COVID-19 infection, while index cases in the incubation period had lower contagiousness. Our findings will be helpful for developing targeted prevention and control strategies to combat the worldwide pandemic.},
author = {Liu, Tao and Liang, Wenjia and Zhong, Haojie and He, Jianfeng and Chen, Zihui and He, Guanhao and Song, Tie and Chen, Shaowei and Wang, Ping and Li, Jialing and Lan, Yunhua and Cheng, Mingji and Huang, Jinxu and Niu, Jiwei and Xia, Liang and Xiao, Jianpeng and Hu, Jianxiong and Lin, Lifeng and Huang, Qiong and Rong, Zuhua and Deng, Aiping and Zeng, Weilin and Li, Jiansen and Li, Xing and Tan, Xiaohua and Kang, Min and Guo, Lingchuan and Zhu, Zhihua and Gong, Dexin and Chen, Guimin and Dong, Moran and Ma, Wenjun},
doi = {10.1080/22221751.2020.1787799},
issn = {2222-1751 (Electronic)},
journal = {Emerging microbes {\&} infections},
keywords = {Adolescent,Adult,Age Factors,Aged,Aged, 80 and over,Child,Child, Preschool,China,Cohort Studies,Contact Tracing,Coronavirus Infections,Disease Susceptibility,Female,Humans,Infant,Infant, Newborn,Male,Middle Aged,Pandemics,Pneumonia, Viral,Quarantine,Retrospective Studies,Risk Factors,Young Adult,transmission},
language = {eng},
month = {dec},
number = {1},
pages = {1546--1553},
pmid = {32608325},
title = {{Risk factors associated with COVID-19 infection: a retrospective cohort study based on contacts tracing.}},
volume = {9},
year = {2020}
}
@misc{Ing2020,
author = {Ing, Richard J and Barrett, Cindy and Chatterjee, Debnath and Twite, Mark and Whitney, Gina M},
booktitle = {Journal of cardiothoracic and vascular anesthesia},
doi = {10.1053/j.jvca.2020.04.032},
issn = {1532-8422 (Electronic)},
language = {eng},
month = {sep},
number = {9},
pages = {2307--2311},
pmid = {32451272},
title = {{Perioperative Preparations for COVID-19: The Pediatric Cardiac Team Perspective.}},
volume = {34},
year = {2020}
}
@article{Irham2020,
abstract = {The World Health Organization recently announced that pandemic status has been achieved for coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Exponential increases in patient numbers have been reported around the world, along with proportional increases in the number of COVID-19-related deaths. The SARS-CoV-2 infection rate in a population is expected to be influenced by social practices, availability of vaccines or prophylactics, and the prevalence of susceptibility genes in the population. Previous work revealed that cellular uptake of SARS-CoV-2 requires Angiotensin Converting Enzyme 2 (ACE-2) and a cellular protease. The spike (S) protein on SARS-CoV-2 binds ACE-2, which functions as an entry receptor. Following receptor binding, transmembrane protease serine 2 (encoded by TMPRSS2) primes the S protein to allow cellular uptake. Therefore, individual expression of TMPRSS2 may be a crucial determinant of SARS-CoV-2 infection susceptibility. Here, we utilized multiple large genome databases, including the GTEx portal, SNP nexus, and Ensembl genome project, to identify gene expression profiles for TMPRSS2 and its important expression quantitative trait loci. Our results show that four variants (rs464397, rs469390, rs2070788 and rs383510) affect expression of TMPRSS2 in lung tissue. The allele frequency of each variant was then assessed in regional populations, including African, American, European, and three Asian cohorts (China, Japan and Taiwan). Interestingly, our data shows that TMPRSS2-upregulating variants are at higher frequencies in European and American populations than in the Asian populations, which implies that these populations might be relatively susceptible to SARS-CoV-2 infection.},
author = {Irham, Lalu Muhammad and Chou, Wan-Hsuan and Calkins, Marcus J and Adikusuma, Wirawan and Hsieh, Shie-Liang and Chang, Wei-Chiao},
doi = {10.1016/j.bbrc.2020.05.179},
issn = {1090-2104 (Electronic)},
journal = {Biochemical and biophysical research communications},
keywords = {Asia,Betacoronavirus,Cohort Studies,Europe,Gene Expression Regulation,Gene Frequency,Genetics, Population,Geographic Mapping,Humans,Internationality,Lung,Organ Specificity,Polymorphism, Single Nucleotide,Quantitative Trait Loci,Receptors, Virus,Serine Endopeptidases,United States,Up-Regulation,ethnology,genetics,metabolism},
language = {eng},
month = {aug},
number = {2},
pages = {263--269},
pmid = {32703421},
title = {{Genetic variants that influence SARS-CoV-2 receptor TMPRSS2 expression among population cohorts from multiple continents.}},
volume = {529},
year = {2020}
}
@article{Chen2020,
abstract = {The coronavirus disease-19 (COVID-19) has spread over many countries and regions since the end of 2019, becoming the most severe public health event at present. Most of the critical cases developed multiple organ dysfunction, including acute kidney injury (AKI). Cytokine storm syndrome (CSS) may complicate the process of severe COVID-19 patients. This manuscript reviews the different aspects of blood purification in critically ill patients with AKI and increased inflammatory factors, and examines its potential role in severe COVID-19 treatment. Continuous renal replacement therapy (CRRT) has been practiced in many sepsis patients with AKI. Still, the timing and dosing need further robust evidence. In addition to the traditional CRRT, the high-throughput membrane with adsorption function and cytokine adsorption column are two representatives of recently emerging novel membrane technologies. Their potential in removing inflammatory factors and other toxins prospects for the treatment of severe COVID-19.},
author = {Chen, Gang and Zhou, Yangzhong and Ma, Jie and Xia, Peng and Qin, Yan and Li, Xuemei},
doi = {10.1080/0886022X.2020.1764369},
issn = {1525-6049 (Electronic)},
journal = {Renal failure},
keywords = {Betacoronavirus,Calcinosis,Coronavirus Infections,Critical Illness,Cytokines,Heart Valve Diseases,Humans,Hypotrichosis,Pandemics,Pneumonia, Viral,Renal Replacement Therapy,Skin Diseases, Genetic,complications,etiology,therapy},
language = {eng},
month = {nov},
number = {1},
pages = {483--488},
pmid = {32438839},
title = {{Is there a role for blood purification therapies targeting cytokine storm syndrome in critically severe COVID-19 patients?}},
volume = {42},
year = {2020}
}
@article{Kulkarni2020,
abstract = {BACKGROUND: There are few reports of COVID-19 in neonates and most are suspected to be due to postnatal transmission. Vertical transmission has been proven in only a couple of cases so far. METHODS: We describe early-onset, severe COVID-19 disease in a neonate with very strong evidence of vertical transmission of SARS-CoV-2. RESULTS: A COVID-19 suspected mother, who tested negative by RT-PCR for COVID, but tested positive for SARS-CoV-2 by serology, delivered a term baby. The neonate was kept in strict isolation. Molecular tests for SARS-CoV-2 on umbilical stump, placenta, and nasopharyngeal aspirate of the neonate, collected at birth were positive. On day 2, the neonate developed clinical features of COVID in the form of fever, poor feeding, and hyperbilirubenemia along with elevated inflammatory markers. Antibiotics were started empirically pending cultures. Blood, CSF, and urine cultures were sterile. Baby tested RT-PCR positive for SARS-CoV-2 on two more occasions before testing positive for antibodies and was discharged on day 21 of life. CONCLUSION: This report highlights a very strong possibility of vertical transmission of COVID-19 from a mildly symptomatic, RT-PCR negative but antibody-positive mother with significant symptomatic, early-onset neonatal infection.},
author = {Kulkarni, Rajesh and Rajput, Uday and Dawre, Rahul and Valvi, Chhaya and Nagpal, Rema and Magdum, Nikita and Vankar, Harshali and Sonkawade, Naresh and Das, Aiswarya and Vartak, Sagar and Joshi, Suvarna and Varma, Santosh and Karyakarte, Rajesh and Bhosale, Ramesh and Kinikar, Aarti},
doi = {10.1007/s15010-020-01493-6},
issn = {1439-0973 (Electronic)},
journal = {Infection},
language = {eng},
month = {aug},
pmid = {32743723},
title = {{Early-onset symptomatic neonatal COVID-19 infection with high probability of vertical transmission.}},
year = {2020}
}
@article{Wen2020,
abstract = {The ongoing worldwide SARS-CoV-2 epidemic clearly has a tremendous influence on public health. Molecular detection based on oral swabs was used for confirmation of SARS-CoV-2 infection. However, high false negative rates were reported. We describe here the development of a point-of-care (POC) serological assay for the detection of IgG antibody against SARS-CoV-2. The principle of a lateral flow immunoassay strip (LFIAs) consists of fixing SARS-CoV-2 nucleocapsid protein to the surface of the strip and coupling anti-human IgG with colloidal gold nanoparticles (Au NPs). A series of parameters of this method were optimized, including the concentration of coating antigen, BSA blocking concentration and pH value for conjugation. The entire detection process took 15-20 min with a volume of 80 $\mu$L of the analyte solution containing 10 $\mu$L of serum and 70 $\mu$L sample diluent. The performance of the established assay was evaluated using serum samples of the clinically diagnosed cases of Coronavirus Disease 2019 (COVID-19). Our results indicated that the LFIAs for SARS-CoV-2 had satisfactory stability and reproducibility. As a result, our fast and easy LFIAs could provide a preliminary test result for physicians to make the correct diagnosis of SARS-CoV-2 infections along with alternative testing methods and clinical findings, as well as seroprevalence determination, especially in low-resource countries.},
author = {Wen, Tian and Huang, Chao and Shi, Feng-Juan and Zeng, Xiao-Yan and Lu, Tian and Ding, Shou-Nian and Jiao, Yong-Jun},
doi = {10.1039/d0an00629g},
issn = {1364-5528 (Electronic)},
journal = {The Analyst},
language = {eng},
month = {aug},
number = {15},
pages = {5345--5352},
pmid = {32568341},
title = {{Development of a lateral flow immunoassay strip for rapid detection of IgG antibody against SARS-CoV-2 virus.}},
volume = {145},
year = {2020}
}
@article{North2020,
abstract = {This article aims to give a brief outline of the pathogenesis and transmission of SARS-CoV-2 and how to safely navigate an arthroplasty practice during and after the pandemic.},
author = {North, Trevor and Bullock, Matthew W and Danoff, Jonathan R and Saxena, Arjun and Fischer, Stuart J and Stronach, Ben M and Levine, Brett R},
doi = {10.1016/j.artd.2020.05.011},
issn = {2352-3441 (Print)},
journal = {Arthroplasty today},
language = {eng},
month = {sep},
number = {3},
pages = {427--430},
pmid = {32572379},
title = {{Arthroplasty during the COVID-19 Pandemic.}},
volume = {6},
year = {2020}
}
@article{Wang2020,
abstract = {The purpose of this study was to investigate the feasibility of serological total antibody tests combined with RT-PCR for detection of SARS-COV-2. We conducted a retrospective study in which 375 patients were enrolled during the outbreak of SARS-COV-2 from 25th January to 16th March 2020. Patients were divided into a COVID-19 group (n = 141) and a control group (n = 234). Serum samples and throat swabs were collected from 375 patients for total antibody testing against SARS-COV-2 and RT-PCR analysis, respectively. The results indicated that diagnostic sensitivity and specificity were 95.7 {\%} and 98.7 {\%}, 92.2 {\%} and 100 {\%} by total antibody tests and RT-PCR, respectively. The sensitivity and specificity of total antibody tests combined with RT-PCR were 98.6 {\%} and 98.7 {\%}. The sensitivity of the combined method was significantly higher than RT-PCR (X(2) = 5.16, P {\textless} 0.05), and similar to that of total antibody tests (X(2) = 1.15, P{\textgreater} 0.05). This study supported the advantage of the combined method for detection of SARS-COV-2 with a high degree of sensitivity and specificity, as a useful tool for accurate diagnosis and timely treatment of suspected patients, epidemiological investigation, as well as monitoring ongoing outbreaks of infections with SARS-COV-2.},
author = {Wang, Pei},
doi = {10.1016/j.jviromet.2020.113919},
issn = {1879-0984 (Electronic)},
journal = {Journal of virological methods},
keywords = {Adolescent,Adult,Aged,Antibodies, Viral,Betacoronavirus,Case-Control Studies,China,Coronavirus Infections,Female,Humans,Immunoassay,Luminescent Measurements,Male,Middle Aged,Pandemics,Pneumonia, Viral,Real-Time Polymerase Chain Reaction,Retrospective Studies,Sensitivity and Specificity,Serologic Tests,Young Adult,blood,diagnosis,immunology,methods},
language = {eng},
month = {sep},
pages = {113919},
pmid = {32554043},
title = {{Combination of serological total antibody and RT-PCR test for detection of SARS-COV-2 infections.}},
volume = {283},
year = {2020}
}
@article{VanRheenen2020,
abstract = {BACKGROUND: Physical-distancing strategies during the coronavirus (COVID-19) pandemic may be particularly detrimental to the mental health of individuals with a pre-existing mood disorder. Data on the mental health status of these individuals during the current pandemic is sparse, and their current mental health needs unclear. METHOD: We characterised COVID-19 related lifestyle changes, primary concerns and psychological distress in n=1292 respondents self-reporting a mood disorder (either bipolar disorder or depressive disorder) and n=3167 respondents without any reported mental disorder from the COLLATE (COvid-19 and you: mentaL heaLth in AusTralia now survEy) project; an Australian national survey launched on April 1(st) 2020. RESULTS: Psychological distress was heightened in the mood disorder group compared to the group with no mental disorder, with stress and depression further elevated in respondents with bipolar disorder compared to those with depressive disorder; and men with bipolar disorder having even higher levels of depression than women with bipolar disorder. Respondents with bipolar disorder were particularly concerned about financial issues associated with COVID-19 compared to those with depressive disorder and those with no mental disorder. Adverse changes to lifestyle behaviours were more prevalent in respondents with a mood disorder and linked to higher levels of distress. LIMITATIONS: Mood disorder was self-reported and was not clinically verified. CONCLUSIONS: Current psychological distress levels are elevated in individuals with mood disorder and are associated with maladaptive situational and lifestyle changes occurring in response to COVID-19.},
author = {Van Rheenen, Tamsyn E and Meyer, Denny and Neill, Erica and Phillipou, Andrea and Tan, Eric J and Toh, Wei Lin and Rossell, Susan L},
doi = {10.1016/j.jad.2020.06.037},
issn = {1573-2517 (Electronic)},
journal = {Journal of affective disorders},
language = {eng},
month = {oct},
pages = {69--77},
pmid = {32658826},
title = {{Mental health status of individuals with a mood-disorder during the COVID-19 pandemic in Australia: Initial results from the COLLATE project.}},
volume = {275},
year = {2020}
}
@article{Schrezenmeier2020,
abstract = {PURPOSE OF REVIEW: The current review highlights recent insights into direct antiviral effects by antimalarials against severe acute respiratory syndrome (SARS)-CoV-2 and other viruses and their potential indirect effects on the host by avoiding exaggerated immune responses (reduced cytokine release, Toll-like receptor response, antigen presentation related to lysosomal processing). RECENT FINDINGS: Currently, there is a large debate on the use of antimalarials for prophylaxis and treatment of SARS-CoV-2-induced disease based on preclinical in-vitro data, small case series and extrapolation from earlier studies of their effect on intracellular pathogens, including many viruses. Hydroxychloroquine (HCQ) or chloroquine have not demonstrated robust efficacy in prior randomized controlled studies against several other viruses. In-vitro data indicate a reduced viral replication of SARS-CoV-2. Especially immunomodulatory effects of antimalarials might also contribute to a clinical efficacy. For SARS-CoV-2 various large studies will provide answers as to whether antimalarials have a place in prophylaxis or treatment of the acute virus infection with SARS-CoV-2 but compelling data are missing so far. SUMMARY: In-vitro data provide a theoretical framework for an efficacy of antimalarials in SARS-CoV-2-induced disease but clinical proof is currently missing.},
author = {Schrezenmeier, Eva V and Burmester, Gerd R and Eckardt, Kai-Uwe and D{\"{o}}rner, Thomas},
doi = {10.1097/BOR.0000000000000731},
issn = {1531-6963 (Electronic)},
journal = {Current opinion in rheumatology},
language = {eng},
month = {sep},
number = {5},
pages = {449--457},
pmid = {32675717},
title = {{Role for antimalarials in the management of COVID-19.}},
volume = {32},
year = {2020}
}
@article{Sotoca2020,
author = {Sotoca, Javier and Rodr{\'{i}}guez-{\'{A}}lvarez, Yensa},
doi = {10.1212/NXI.0000000000000803},
issn = {2332-7812 (Electronic)},
journal = {Neurology(R) neuroimmunology {\&} neuroinflammation},
keywords = {Acute Disease,Aged,Betacoronavirus,Coronavirus Infections,Female,Humans,Myelitis, Transverse,Pandemics,Pneumonia, Viral,complications,diagnostic imaging,etiology},
language = {eng},
month = {sep},
number = {5},
pmid = {32522767},
title = {{COVID-19-associated acute necrotizing myelitis.}},
volume = {7},
year = {2020}
}
@article{Koenig2020,
abstract = {An exacerbated and unbalanced immune response may account for the severity of COVID-19, the disease caused by the novel severe acute respiratory syndrome (SARS) coronavirus 2, SARS-CoV-2. In this Viewpoint, we summarize recent evidence for the role of neutrophils in the pathogenesis of COVID-19 and propose CXCR2 inhibition as a promising treatment option to block neutrophil recruitment and activation.},
author = {Koenig, Lars M and Boehmer, Daniel F R and Metzger, Philipp and Schnurr, Max and Endres, Stefan and Rothenfusser, Simon},
doi = {10.1084/jem.20201342},
issn = {1540-9538 (Electronic)},
journal = {The Journal of experimental medicine},
keywords = {Betacoronavirus,Coronavirus Infections,Humans,Inflammation,Pandemics,Pneumonia, Viral,epidemiology},
language = {eng},
month = {sep},
number = {9},
pmid = {32678432},
title = {{Blocking inflammation on the way: Rationale for CXCR2 antagonists for the treatment of COVID-19.}},
volume = {217},
year = {2020}
}
@article{Su2020,
abstract = {This study aims to analyze the different clinical characteristics between children and their families infected with severe acute respiratory syndrome coronavirus 2. Clinical data from nine children and their 14 families were collected, including general status, clinical, laboratory test, and imaging characteristics. All the children were detected positive result after their families onset. Three children had fever (22.2{\%}) or cough (11.2{\%}) symptoms and six (66.7{\%}) children had no symptom. Among the 14 adult patients, the major symptoms included fever (57.1{\%}), cough (35.7{\%}), chest tightness/pain (21.4{\%}), fatigue (21.4{\%}) and sore throat (7.1{\%}). Nearly 70{\%} of the patients had normal (71.4{\%}) or decreased (28.6{\%}) white blood cell counts, and 50{\%} (7/14) had lymphocytopenia. There were 10 adults (71.4{\%}) showed abnormal imaging. The main manifestations were pulmonary consolidation (70{\%}), nodular shadow (50{\%}), and ground glass opacity (50{\%}). Five discharged children were admitted again because their stool showed positive result in SARS-CoV-2 PCR. COVID-19 in children is mainly caused by family transmission, and their symptoms are mild and prognosis is better than adult. However, their PCR result in stool showed longer time than their families. Because of the mild or asymptomatic clinical process, it is difficult to recognize early for pediatrician and public health staff.},
author = {Su, Liang and Ma, Xiang and Yu, Huafeng and Zhang, Zhaohua and Bian, Pengfei and Han, Yuling and Sun, Jing and Liu, Yanqin and Yang, Chun and Geng, Jin and Zhang, Zhongfa and Gai, Zhongtao},
doi = {10.1080/22221751.2020.1744483},
issn = {2222-1751 (Electronic)},
journal = {Emerging microbes {\&} infections},
keywords = {Adult,Betacoronavirus,Chest Pain,Child,Child, Preschool,China,Clinical Laboratory Techniques,Coronavirus Infections,Cough,Family Health,Feces,Female,Fever,Humans,Infant,Lung,Male,Pandemics,Pneumonia, Viral,Polymerase Chain Reaction,Prognosis,Retrospective Studies,diagnosis,diagnostic imaging,physiopathology,virology},
language = {eng},
month = {dec},
number = {1},
pages = {707--713},
pmid = {32208917},
title = {{The different clinical characteristics of corona virus disease cases between children and their families in China - the character of children with COVID-19.}},
volume = {9},
year = {2020}